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ABSTRACT 
 
RAD51 protein plays an important role in homologous genetic recombination (HR), an essential 
DNA metabolic process used by cells to faithfully repair the most deleterious forms of DNA 
damage and maintain genomic integrity. RAD51 along with its bacterial counterpart RecA, 
bacteriophage UvsX and archaeal RadA have been subjected to genetic and biochemical scrutiny 
resulting in a plentitude of mechanistic and functional information on formation, regulation and 
activities of these recombinases. An important disconnect between these two lines of investigation 
still exists because the recombinase functions of RAD51 are highly regulated through mediator 
proteins like the BRCA2 recombination mediator, and a host of post translational modifications, 
namely phosphorylation. The mechanism and biochemical implications of these regulatory 
processes have not been satisfactorily evaluated in-vitro.  
 
This work characterizes the interaction between RAD51 and the BRCA2 recombination mediator 
protein using computational methods to generate homology models for this interaction which are 
validated through experimental data. Using the knowledge gained from our structural model for 
the RAD51 recombinase, I developed a novel strategy to understand several key mechanisms for 
the regulation of RAD51 by phosphorylation. RAD51 is phosphorylated by the cABL tyrosine 
kinase. The mechanistic and functional significance of this event is largely disputed.  Using 
biochemical and single molecule assays reconstituting major activities of RAD51, I have 
successfully dissected the biochemical mechanism of regulation of RAD51 by the c-Abl kinase. 
The results of this work strongly correlate with observations made in previous cell based analysis. 
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CHAPTER 1: INTRODUCTION 
Double stranded DNA (dsDNA) is the carrier of genetic information throughout life. The genomic 
DNA in all living organisms is constantly subjected to change. Most of these changes are 
mechanisms evolved to protect the integrity of the DNA or aid in its function as a repository of 
information storage. However, certain types of modifications are detrimental to the integrity of the 
genome. These sources of ‘DNA Damage’ range from external factors such as ultraviolet light 
(UV), Ionizing radiation (IR), environmental pollutants such as heavy metals as well as chemical 
substances that are intentionally created to damage DNA (e.g. chemotherapeutic agents), to 
internal biological processes like DNA hydrolysis, oxidative stress and enzymatic DNA damage 
due to replication errors and other sources (Hoeijmakers 2009; Lindahl, 1993). It is essential that 
mechanisms be available to the organisms to be able to correct for these aberrations. The various 
types of DNA damage include base modifications, abasic sites, inter-strand cross links (ICL’s), 
Single Strand Breaks (SSB’s) and DNA Double Strand Breaks (DSB’s) (Hoeijmakers 2009; Iyama 
and Wilson Iii, 2013; Lindahl, 1993) (Figure 1.1). Coupled with environmental factors, DNA 
damaging agents can lead to ~105 lesions per day (Ciccia and Elledge, 2010; Hoeijmakers 2009). 
This can cause critical mutations in the genome which manifest in the form of cancers, multiple 
inherited disorders, ageing and even cell death (Kanaar et al., 1998).  
 
Figure 1.1 DNA damage and repair responses. DNA repair pathways (top) and examples of corresponding DNA damage 
(bottom). The detailed molecular mechanisms for the repair responses are provided in text. APTX, aprataxin; BER, base excision 
repair; DSBR, DNA double strand break repair; HR, homologous recombination; MGMT, O6-methylguanine-DNA 
methyltransferase; MMR, mismatch repair; NER, nucleotide excision repair; NHEJ, nonhomologous end joining; PNKP, 
polynucleotide kinase 3-phosphatase; SSBR, DNA single strand break repair; SSBs, DNA single strand breaks; TC-NER, 
transcription-coupled NER; TDP1, tyrosyl-DNA phosphodiesterase 1; G-Me, O6-Methylguanine; TˆT, thymine dimer; I, inosine; 
U, uracil; Go, 8-oxoguanine. Reproduced with permission from Iyama T & Wilson Iii DM (2013), DNA repair 12(8):620-636. 
Copyright Elsevier B.V. 
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The mechanisms that preserve the genomic integrity of the cell are collectively referred to as the 
‘DNA repair’ pathways. These pathways, each, focusing on particular type of DNA damage, along 
with cellular checkpoint mechanisms that coordinate replication, transcription, chromatin 
remodeling and generating genetic diversity ensure the maintenance of genomic integrity inside 
the cell (Hoeijmakers 2009).  
 
The choice of DNA repair pathway is largely dependent on the type of DNA damage, 
however the state of the cell cycle is also an important factor in selection of appropriate pathway 
as all pathways are tightly regulated and are active during different stages of the cell cycle. Base 
Excision Repair (BER) is generally the pathway of choice for DNA damage that does not severely 
affect the helical structure of the DNA. Such damage occurs through base modifications, 
alkylation, deamination, depurination as well as certain single strand breaks (Figure 1.1) (Krokan 
and Bjørås, 2013; Wallace, 2014). During BER, the damaged base is first excised, followed by 
end processing, gap filling and finally ligation which restores the DNA (Krokan and Bjørås, 2013). 
Nucleotide Excision Repair (NER) is responsible for removal of bulky DNA lesions that 
destabilize the duplex DNA caused by UV radiation and other mutagens. The NER pathway can 
be triggered through Global Genome NER (GG-NER) which can occur anywhere in the genome 
and is generally activated by UV damage or Transcription Coupled NER (TC-NER) which is 
activated by RNA polymerase stalled at a lesion during transcription (Schärer, 2013). It involves 
removal of a small tract of DNA ~13 bases long (Kisker et al., 2013) followed by a polymerase 
that fills in the gap repairing the DNA (Schärer, 2013). Errors made by the replication machinery 
lead to mismatched bases and are repaired by the Mismatch Repair (MMR) pathway where the 
mismatched bases are detected, excised and the gap filled in (Honda et al., 2014; Kolodner, 1996). 
Double strand breaks (DSB’s) are the most deleterious forms of DNA damage which can lead to 
severe loss of genetic information. These are discussed further. 
 
Sources of Double Strand Breaks 
DNA damage due to Double Strand Breaks (DSB’s) is less frequent compared to other forms of 
lesions but comprise the most deleterious and cytotoxic forms of DNA damage (Mehta and Haber, 
2014) and repairing these forms of damage are of the utmost priority for the cell. This type of 
damage involves the simultaneous breakdown of the phosphodiester backbones of both strands of 
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DNA. Agents that cause DSB’s include certain anticancer agents (clastogens) and Ionizing 
Radiation (IR). Chemotherapeutic agents include methyl methanosulfonate (MMS) and 
temozolomide which alkylate DNA. Agents like Mitomycin C and Cisplatin induce DNA 
crosslinks while compounds such as Bleomycin mimic radiation damage. Inhibitors such as 
etoposide trap topoisomerases inducing DSB’s. (Mehta and Haber, 2014). Ionizing Radiation (IR) 
produces reactive oxygen species which attach the sugar phosphate backbone and in high doses 
can cause breaks in complementary strands of DNA leading to DSB’s (Hoeijmakers 2009).  
 
In addition to these exogenous agents, DNA is very vulnerable to the formation of DSB’s 
during the natural replicative cycle of the cell. Unusual DNA structures or collisions with 
transcription machinery lead to stalled replication forks which can cause DBS’s (Aguilera and 
Gaillard, 2014). Programmed DSB’s are initiated by the cell in several instances which lead to 
genetic diversity during meiosis (Keeney, 2008; Lam and Keeney, 2015) as well as generation of 
antibody diversity by V(D)J recombination (Soulas-Sprauel et al., 2007).  
 
Repair of DNA Double Strand Breaks 
There are two main pathways that the cell uses to repair DSB’s, Non Homologous End Joining 
(NHEJ) and Homologous Recombination (HR) (Kass and Jasin, 2010). NHEJ involves the limited 
modification of broken DNA ends followed by their ligation (Mehta and Haber, 2014). Alternative 
NHEJ (alt-NJEJ) pathways are executed when canonical NHEJ is unavailable with the propensity 
to create mutations, because joints often harbor local deletions with relatively long stretches of 
microhomology, itself often called MMEJ (Chiruvella et al., 2013). In higher eukaryotes, NHEJ 
activities are active through all stages of the cell cycle but are generally limited to the G1 stage 
where key components of the HR pathway are blocked (Aylon et al., 2004; Ira et al., 2004). It is 
defined as the Joining of two DSB ends by direct ligation (Chiruvella et al., 2013). Since this 
process need not result in accurate repair of the DNA, it is recognized as being error prone or an 
unfaithful mechanism of Double Strand Break Repair (DSBR). Briefly, NHEJ involves the binding 
of the DSB ends by the Ku protein complex which activate a slew of NHEJ associated proteins 
through the DNA Protein Kinase (DNA-PK) through association. The ends are then ligated by the 
DNA Ligase IV and any gaps filled in by the DNA polymerase X (PolX) (Chiruvella et al., 2013) 
(Figure 1.2).   
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Figure 1.2 General steps of Non Homologous DNA end joining (NHEJ). The lightning arrow indicates ionizing radiation (IR), 
a reactive oxygen species (ROS), or an enzymatic cause of a DSB. Ku binding to the DNA ends at a double-strand breaks (DSBs) 
improves binding by nuclease, DNA polymerase, and ligase components. Note that Ku is thought to change conformation upon 
binding to the DNA end, as depicted by its shape change from a sphere to a rectangle. Flexibility in the loading of these enzymatic 
components, the option to load repeatedly (iteratively), and independent processing of the two DNA ends all permit mechanistic 
flexibility for the NHEJ process. This mechanistic flexibility is essential to permit NHEJ to handle a very diverse array of DSB end 
configurations and to join them. In addition to the overall mechanistic flexibility, each component exhibits enzymatic flexibility 
and multifunctionality, as discussed in the text. The figure shows that there are many alternative intermediates in the joining process 
(middle). These intermediates are reflected in a diverse DNA sequences at the junction of the joining process (bottom). Reproduced 
from, Lieber MR (2010) Annual review of biochemistry 79:181-211, Copyright Annual Reviews. 
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Accurate repair of DSB’s is reliant on the set of homology-directed DNA repair pathways 
that result in the faithful restoration of the damaged DNA to its original state without the loss of 
any sequence information. DNA repair through Homologous Recombination (HR) requires a 
second homologous DNA (donor sequence), from the homologous chromosome or the sister 
chromatid, as a template for the lost DNA sequence. If the donor sequence is similar to the region 
surrounding the DSB, the repair is accurate and the DNA sequence is restored to that preceding 
the DNA damage (Moynahan and Jasin, 2010). 
 
Figure. 1.3 Pathways of DNA DSB repair. Double-strand breaks (DSBs) are efficiently repaired in mammalian cells by 
homologous recombination (HR) and non-homologous end joining (NHEJ). HR initiates with end resection, which produces a 3′ 
single-stranded end that can invade a homologous template to initiate repair. Alternative HR pathways can ensue from the 
displacement loop (D-loop) intermediate: synthesis-dependent strand annealing (SDSA) and DSB repair (DSBR). In SDSA, the 
newly synthesized strand is displaced to anneal to the other DNA end, resulting in a non-crossover outcome with no change to the 
template DNA. In DSBR, the second DNA end is ‘captured’ by the D-loop to form a double Holliday junction, which in principle 
can result in a non-crossover (cleavage at black or grey arrowheads) or a crossover (cleavage at black arrowheads on one side and 
grey arrowheads) outcome. NHEJ involves the joining of non-homologous DNA ends. It can be imprecise and lead to deletions 
and other mutations through numerous end-processing steps (not shown). Single-strand annealing takes place when end resection 
occurs at sequence repeats (arrowheads) to provide complementary single strands that anneal, giving rise to a product with a single 
copy of the repeat and a deletion of intervening sequences. Reproduced with permission from, Moynahan ME & Jasin M (2010) 
Nature reviews. Molecular cell biology 11(3):196-207, Copyright Macmillan Publishers Limited. 
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 The central step in homologous recombination involves the formation of a nucleoprotein 
filament which invades the homologous DNA template searching for homology ending in the 
forming a D-Loop intermediate. This intermediate is then funneled into different pathways which 
lead to the repair of the damaged DNA (Figure 1.3) (Moynahan and Jasin, 2010). Like all DNA 
repair pathways, DSBR is initiated by a DNA damage sensing mechanism which involves the 
immediate recruitment of the MRN (MRE11-RAD50-NBS1) complex, which binds dsDNA ends. 
This leads to the activation of the ATM (ataxia-telangiectasia mutated) and ATR (ATM- and Rad3-
Related) kinases (Lee and Paull, 2007; Maréchal and Zou, 2013), while simultaneously initiating 
DNA resection (generation of 3` ssDNA ends) through the exonuclease activity of the MRE11 
protein (Symington, 2014). The resection process is then handed to the CtIP/EXO1/BLM or 
BLM/DNA2/RPA complex (Nimonkar et al., 2011), which generate ssDNA ends that are bound 
by the ssDNA binding protein RPA. The ATM/ATR kinases activated here in turn activates 
phosphorylates a number of proteins involved in cell cycle checkpoint control, apoptotic responses 
and DNA repair. Phosphorylation of these substrates by ATM initiates cell-cycle arrest at G1/S, 
intra-S and G2/M checkpoints and promotes DNA repair (Lee and Paull, 2007). The active 
intermediate for the strand invasion step is the RAD51-ssDNA nucleoprotein filament. This 
filament is formed by displacement of the RPA coated ssDNA by the BRCA2 protein which binds 
RAD51 through its BRC repeats (Carreira et al., 2009; Shahid et al., 2014) and helps nucleoprotein 
filament assembly along with several other mediator proteins (Suwaki et al., 2011; Zelensky et al., 
2014a) which stabilize the RAD51 filaments. The active nucleoprotein filament then invades the 
homologous DNA template forming a Displacement Loop (D-Loop) intermediate (Figure 1.3). 
The invaded strand is then extended at the 3`-OH end with the help of the RAD54 protein and 
DNA polymerases (Li and Heyer, 2009; Murakami and Trakselis, 2014). At this stage the D-Loop 
can be disassembled by structure selective helicases in which the complementary strand anneals 
with the single-stranded tail of the other end of the DSB. After fill-in synthesis and ligation, this 
pathway generates non-crossover products and is referred to as synthesis-dependent strand 
annealing (SDSA) (Prakash et al., 2009) (Figure 1.4).  
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Figure 1.4 Series of events following formation of D-Loops in Double Strand Break Repair. Once formed, the complex of 
RAD51 and single-stranded DNA searches for a homologous sequence in double-stranded DNA and then promotes invasion of the 
single-stranded DNA into donor double-stranded DNA to form a joint molecule with a displaced strand (D loop). RAD54 displaces 
RAD51 from double-stranded DNA in vitro, uncovering the 3′ end of paired intermediates to allow initiation of DNA synthesis. 
DNA polymerase δ extends the 3′ end from the broken chromosome using the donor strand as a template and replacing nucleotides 
lost by end resection. To resolve the intermediate by synthesis-dependent strand annealing, the invading strand that has been 
extended by DNA synthesis is displaced (strand displacement) and anneals to complementary sequences exposed by 5′–3′ resection 
of the other side of the break forming non-crossover products exclusively (strand annealing). In addition to preventing initiation of 
inappropriate recombination events by disrupting RAD51 nucleoprotein filaments, the FBH1 DNA helicase can disrupt D loop 
intermediates to promote non-crossover. The FBH1 and RTEL1 helicases also dissociate D loop intermediates to facilitate 
synthesis-dependent strand annealing. In the canonical DNA double-strand break repair model, the other end of the break interacts 
with the displaced strand of the strand invasion intermediate (second end capture) and the 3′ end primes DNA synthesis, forming a 
double Holliday junction (dHJ) intermediate (double Holliday junction formation). The dHJ intermediates can be dissolved or 
resolved to yield separate intact duplex molecules. Alternatively, the extended D loop structure could be cleaved by the MUS81-
EME1 nuclease prior to formation of a mature dHJ intermediate (early D loop cleavage). MUS81-EME1 exhibits higher activity 
toward D loop and nicked Holliday junction intermediates than intact Holliday junctions and could promote crossovers by cleaving 
the strand invasion intermediate directly. Dissolution of dHJ intermediates requires the combined activity of the BLM helicase, 
which drives migration of the constrained Holliday junctions, and the TOPIIIα-RMI1/2 complex, which decatenates the interlinked 
strands between the two Holliday junctions eventually leading to non-crossover products. On the other hand, resolution through 
nucleolytic cleavage of the Holliday junctions can yield crossover (cutting inner strands of one Holliday junction and outer strands 
of the other) or non-crossover (cutting both junctions in the same plane) products. Adapted with permission from, Mazon G, 
Mimitou EP, & Symington LS (2010) SnapShot: Homologous recombination in DNA double-strand break repair. Cell 142(4):646, 
646 e641. Copyright Elsevier Inc. 
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An alternative mechanism involves formation of joint-molecules such as single or double 
Holliday Junctions (HJ’s) which can either be dissolved by the BTR, (BLM-TOPIIIα-RMI1-
RMI2) complex leading to a non-crossover event (Bizard and Hickson, 2014), or be resolved by 
the structure-selective nucleases, such as MUS81-EME1, SLX1-SLX4, and GEN1 proteins which 
can produce crossover or non-crossover products (Wyatt and West, 2014) (Figure 1.4). 
 
Homologous Recombination in DNA Replication 
In addition to faithfully repairing damaged DNA, the cell has to ensure the faithful and complete 
replication of the chromosomes to maintain genomic integrity during cell division. Replication 
forks are susceptible to stalling or collapse when the replication machinery encounters secondary 
structure in DNA, DNA bound proteins or DNA lesions. Several chemicals like hydroxyurea and 
aphidicolin inhibit replication leading to stalled or collapsed replication forks.  
 
 
Figure 1.5 Models of replication fork restart. a | Restart by fork remodeling. A stalled replication fork might be stabilized by the 
re-annealing of single-strand DNA (ssDNA) generated by excessive unwinding of the template, or might undergo regression and 
pairing of the newly synthesized strands to form a Holliday junction in a structure termed a ‘chicken foot’. Restart after Holliday 
junction formation may be difficult if it requires the removal and subsequent re-loading of the replication machinery. b | Holliday 
junction‑mediated fork restart. The double-stranded DNA (dsDNA) end of the Holliday junction is recombined into the template 
through strand invasion, forming a displacement loop (D‑loop). In E. coli, the D‑loop allows re-loading of the replication 
machinery. The invading strand re-anneals with the template, forming a double Holliday junction that can be removed by Holliday 
junction resolution, which leads to sister chromatid exchanges, or Holliday junction dissolution, which avoids the generation of 
9 
 
recombination products. c | Double-strand break (DSB)-mediated restart. The Holliday junction is processed into a one-ended DSB 
and fork restart is achieved through homologous recombination repair of the DSB in a mechanism analogous to break-induced 
replication. The resulting single Holliday junction would be resolved by Holliday junction resolution. The leading strand and 
leading-strand template are shown in light and dark blue, respectively, and the lagging strand and lagging-strand template are shown 
in light and dark red, respectively. Reproduced with permission from Petermann E & Helleday T (2010) Nature reviews. Molecular 
cell biology 11(10):683-687, Copyright Macmillan Publishers Limited. 
 
 
 Restarting stalled or collapsed replication forks occurs through several pathways 
(Petermann and Helleday, 2010) (Figure 1.5), most of which require processing by the DSBR 
machinery which is dependent on recombination and hence necessitates the participation of the 
RAD51 protein.  Collapsed replication forks leads to generation of single ended DSB’s which are 
processed by the end resection machinery (Franchitto and Pichierri, 2002), which helps loading of 
RAD51 onto the resected ssDNA ends. The nucleoprotein filament then invades the other 
replicating strand forming D-Loops which eventually lead to replication fork restart (Figure 1.5c). 
In addition to DSB mediated fork restart, RAD51 is also implicated in Holliday Junction mediated 
restart (Figure 1.5b) which does not require the presence of a double strand break (Petermann et 
al., 2010). 
 
The RAD51 Recombinase 
RAD51 recombinase, is the eukaryotic homolog of the Escherichia coli RecA protein. The 
yeast RAD51 gene is a member of the RAD52 epistasis group, which includes RAD50, RAD51, 
RAD52, RAD54, RAD55, and RAD57 genes (Game, 1983), which were initially identified as 
mutants defective in the repair of DNA damage caused by ionizing irradiation and were 
subsequently shown to be deficient in both genetic recombination and the repair of DNA lesions 
(Baumann et al., 1996). Homozygous deletions for the RAD5l null mutation (RAD5 -/-), in mice 
were found to be embryonically lethal (Lim and Hasty, 1996; Tsuzuki et al., 1996); suggesting an 
important role for RAD51 in cell proliferation and development. RAD51 protein was found to 
catalyze DNA strand exchange through the recombinational “D-Loop” intermediate in an ATP 
dependent manner (Baumann et al., 1996; Sung, 1994; Sung and Robberson, 1995). These 
biochemical studies cemented the role of RAD51 as a recombinase protein which enabled 
homologous recombination in the eukaryotic cell.  
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The RAD51 protein has been investigated very extensively through the years, which has 
led to a wealth of information regarding its biochemical properties. The Human RAD51 is a 339 
amino acid long, 37.5KDa protein. The structure of the RAD51 protein is highly conserved among 
eukaryotes, and the human RAD51 homolog exhibits 67% sequence identity to its yeast 
counterpart (Shinohara et al., 1993; Yoshimura et al., 1993). RAD51 has considerably slow ATP 
hydrolytic activity compared to the E. coli RecA protein (Tombline and Fishel, 2002), but binds 
ssDNA similarly, in an ATP dependent manner (Sung and Robberson, 1995) forming a right 
handed helical filament on ssDNA with a mean helical pitch of ~96Å, extending its contour length 
to 1.5 times of the B-Form DNA which corresponds to an axial rise of -18.6 bases of ssDNA per 
helical repeat of the nucleoprotein filament (Sung and Robberson, 1995) (Figure 1.6). RAD51 also 
interacts with dsDNA in a similar ATP dependent manner with a pitch of ~80Å extending its 
contour length to 1.35 times of the B-Form DNA which corresponds to an axial rise of -17.6 base 
pairs per helical repeat of the dsDNA nucleoprotein filament (Ogawa et al., 1993; Sung and 
Robberson, 1995) (Figure 1.6). Studies have shown that in an ssDNA-RAD51 nucleoprotein 
filament, each monomer binds ~3 bases with axial rise per ssDNA base extended to nearly 5 Å 
with the interconversion of sugar puckers inducing horizontal base rotation (Lee et al., 2015; 
Masuda et al., 2009; Nishinaka et al., 1998; Shibata et al., 2001). While RAD51 protein binds 
ssDNA as well as dsDNA substrates similarly, it is the ssDNA-RAD51 filament that is productive 
in strand exchange and homology search, whereas, the RAD51 filament on dsDNA is not only 
incapable of initiating pairing and strand exchange, but is in fact strongly inhibitory to these 
reactions (Sung and Robberson, 1995).  
 
Attempts have also been made to describe the structures of the Human RAD51 but have so 
far been unsuccessful with only one partial structure of its core domain available (Pellegrini et al., 
2002). Since the recombinases are highly conserved across species, crystal structures of E. coli 
RecA (Chen et al., 2008) (Figure 1.7A) and the Saccharomyces cerevisiae Rad51 protein (Conway 
et al., 2004) (Figure 1.7B) have been used to describe the function of the human RAD51 homolog. 
However, due to slight differences in mechanism, filament structure as well as biochemical 
properties and regulation, information from these sources need not be entirely relevant to the 
human RAD51 recombinase. 
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A  B.  
C.  
 
 
Figure 1.6 Structure of the RAD51 nucleoprotein filament. (A) Electron micrographs of a representative RAD51 filament 
formed on ssDNA in the presence of ATP, (B) 3-Dimensional reconstruction of an ssDNA nucleoprotein filament showing a single 
monomer of RAD51. Adapted from (Galkin et al., 2005), Copyright National Academy of Sciences. (C) Electron  micrographs of 
a representative RAD51 filament formed on dsDNA in the presence of ATP. Adapted with permission from Sung P & Robberson 
DL (1995), Cell 82(3):453-461. Copyright Elsevier Inc. 
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A. B.  
Figure 1.7. Crystal Structures of the E. coli RecA and yeast Rad51 Filaments. (A) Structure of the RecA6–(ADP-AlF4-Mg)6–
(dT)18 complex. The six RecA protomers are numbered from the N-terminal RecA of the fusion protein and are coloured pink, 
brown, green, cyan, purple and magenta, respectively. Only 15 of the 18 nucleotides are ordered (red). TheDNAbackbone is traced 
by a red coil. The six ADP-AlF4-Mg molecules are coloured gold. The five individual rotation/translation axes that relate adjacent 
RecA protomers are shown as grey vertical lines. Adapted with permission from, Chen Z, Yang H, & Pavletich NP (2008), Nature 
453(7194):489-484. Copyright Nature Publishing Group. (B) The Rad51 filament found in these crystals has a helical pitch of 130 
Å and is composed of two crystallographically independent monomers (yellow and green) that alternate to form a filament with 
exact three-fold but only approximate six-fold screw symmetry. A sulfate (black spheres) mimics the binding of phosphate in the 
ATPase site, which is nestled directly at the interface between two protomers (arrow). One of the N-terminal domains that line the 
upper surface of the filament is circled. Adapted with permission from, Conway AB, et al. (2004), Nature structural & molecular 
biology 11(8):791-796. Copyright Nature Publishing Group. 
 
 
One of the most important characteristics of the RAD51 nucleoprotein filament is its ability 
to perform homology search. i.e. on invading the homologous duplex DNA, the nucleoprotein 
filament searches for regions of homology forming the heteroduplex DNA (Morrical, 2015). This 
is defined as a dsDNA product that arises from a recombination event. The strands of the 
heteroduplex formed this way can be completely complementary or can contain small regions of 
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non-complementarity. This is stabilized by Watson and Crick pairing that ensures that the 
heteroduplex remains as stable DNA once the recombination machinery dissociates from it. The 
ability to form heteroduplex DNA using strands from two different DNA molecules is central to 
the processes that control genome stability. It allows inheritance of genetic information and genetic 
diversity within the resulting populations (Amunugama et al., 2012a). During meiosis, the RAD51 
protein along with its meiotic homolog DMC1 forms heteroduplex DNA facilitating crossing-over 
and allelic exchange between homologous chromosomes; this process ensures that progeny are not 
identical clones of their parents and ensures a genetically diverse population (Lam and Keeney, 
2015). The mechanism for homology search has intrigued the field for a long time and has been a 
debated topic. How the RAD51 protein is able to find a small region of homology compared to the 
expanse of the genome is staggering. However, research using state-of-the-art single molecule 
methods are beginning to shed new light on this topic. Experiments from these studies show a 
three dimensional search strategy where the nucleoprotein filament initiates intersegmental contact 
between coiled regions of DNA (Forget and Kowalczykowski, 2012) (Figure 1.8A) while 
searching for short regions (~8 nucleotides long) of microhomology between the DNA. The 
nucleoprotein filament can undergo exchange with other regions of dsDNA bearing the same 
microhomology, but resists exchange with unrelated sequences.  
A. B.  
Figure 1.8 Mechanism of 3-Dimensional Homology Search (A). Model for RecA homology search by intersegmental contact 
sampling; for simplicity, only two simultaneous points of interaction are depicted. Adapted with permission from, Forget AL & 
Kowalczykowski SC (2012) Nature 482(7385):423-427. Copyright Macmillan Publishers Limited. (B). Model depicting a 
homology search mechanism involving rapid sampling and rejection of DNA lacking microhomology, followed by eventual capture 
of an 8-nt tract of microhomology and facilitated exchange allowing for an iterative search through sequence space. Adapted with 
permission from Qi Z, et al. (2015), Cell 160(5):856-869. Copyright Elsevier Inc. 
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Moreover, shorter tracts of microhomology are more readily exchanged with longer tracts, 
reflecting the higher stability of intermediates held together by longer tracts of Watson-Crick 
pairing which might in turn funnel the nucleoprotein filament through progressively smaller pools 
of sequences leading to the homologous target (Qi et al., 2015) (Figure 1.8B). 
Mediators in Recombination 
Due to the critical nature of the process of Homologous Recombination (HR), it is 
imperative that it be tightly regulated in the cell.  Excessive DNA rearrangements also need to be 
avoided where they would be disastrous rather than beneficial. Thus, there need to be checkpoints 
at which the reaction can either be driven forward or reversed, an important feature required to 
attain quality control (Holthausen et al., 2011). Recombination mediators are proteins that have 
evolved to ensure quality control of the process of HR. These mediators could have a positive or 
negative effect on HR (Daley et al., 2014a). Proteins like RPA act in both ways paving the way 
for nucleoprotein filament formation by removing secondary structure from resected ssDNA while 
promoting the activities of the DNA resection machinery (Symington, 2014). However, due to its 
high affinity for ssDNA, it kinetically impedes the formation of the RAD51 nucleoprotein filament 
(New et al., 1998). To facilitate the formation of the RAD51 nucleoprotein filament, the BRCA2 
protein sequesters RAD51 monomers and help loading them onto RPA coated ssDNA (Jensen et 
al., 2010; Shahid et al., 2014) (Figure 1.9).  
 
The BRCA2 tumor suppressor, mutations in which have been linked to breast and ovarian 
cancers among other oncogenic conditions (Tavtigian et al., 1996), is a 3418 amino acids long 
protein, containing DNA- and protein-binding domains, and interacts with a number of other 
proteins. The most notable of these interactions are with BRCA1 and PALB2, as deficiencies in 
these proteins manifest similarly to the BRCA2 deficiency (Chen et al., 1999). BRCA2 interacts 
with RAD51 through a set of eight BRC repeats. This interaction has been studied extensively 
(Carreira et al., 2009; Chen et al., 1998; Pellegrini et al., 2002) and has been elaborated on further 
in my research (vida infra). In addition to these mediators, there are a set of proteins in the cell 
that have detectible sequence similarities with the RAD51 protein (Lin et al., 2006; Wiese et al., 
2007). 
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Figure 1.9 RAD51 binding to BRCA2. (a) Overlay of BRCA2 dimer (yellow and cyan) and BRCA2–RAD51 (pink mesh), 
highlighting the differences in their shape. (b) Rearranged BRCA2 dimer fitted into the BRCA2–RAD51 complex. (c) As in b. 
Four RAD51 monomers (orange ribbon) are fitted into the additional density in BRCA2–RAD51 not accounted for by BRCA2 
density. (d) Four RAD51 monomers, arranged as in filaments. Reproduced with permission from, Shahid T, et al. (2014), Nature 
structural & molecular biology 21(11):962-968. Copyright Nature Publishing Group. 
 
 The best characterized of these so-called RAD51 paralogs are RAD51B, RAD51C, 
RAD51D, XRCC2, and XRCC3. These proteins mediate HR by interacting with the RAD51 
protein and aiding as well as stabilizing the nucleoprotein filament. Deficiency in any of these 
proteins results in a homologous recombination phenotype, which is nearly as severe as RAD51 
loss (Amunugama et al., 2013; Suwaki et al., 2011; Zelensky et al., 2014a). Research on these 
RAD51 paralogs is an ongoing and intense area in the DNA repair field. Proteins which act 
16 
 
antagonistically to RAD51 function are only being investigated recently. However some of these 
proteins have already been classified. The RAD54 protein which has been studied extensively in 
yeast, has been shown to stabilize yeast Rad51 filaments on ssDNA and to mediate invasion into 
the nucleosomal DNA, as well as displace Rad51 from dsDNA indicating a role for the clearance 
of Rad51 after strand invasion (Li et al., 2007; Mazin et al., 2010). However, its role in higher 
eukaryotes is not very clear and may be limited to a developmental role since mouse RAD54−/− 
embryonic stem cells are sensitive to IR but the adult RAD54−/− mice are no more IR-sensitive 
than the wild type animals, because their IR-sensitivity is rescued by the non-homologous end-
joining (NHEJ) repair pathway (Essers et al., 2000). Proteins like FBH1 and RTEL are helicases 
that are thought to have antirecombinogenic activity by their ability to dismantle RAD51 mediated 
D-Loops thereby preventing excessive recombination (Simandlova et al., 2013; Vannier et al., 
2012).    
 
Perspective and Overview of my Research 
Importance of RAD51 protein was highlighted by DNA repair defects and embryonic lethality of 
murine RAD51 deletions. RAD51 along with its bacterial counterpart RecA, bacteriophage UvsX 
and archaeal RadA have been subjected to genetic and biochemical scrutiny resulting in a 
plentitude of mechanistic and functional information on formation, regulation and activities of 
these recombinases. An important disconnect between the two lines of investigation still exists 
because the recombinase functions RAD51 are highly regulated through mediator proteins like the 
BRCA2 recombination mediator, and a host of post translational modifications, namely 
phosphorylation. The mechanism and biochemical implications of these regulatory processes have 
not been satisfactorily evaluated in-vitro.  
 
Due to the lack of extensive and complete structural information available for the RAD51 
protein, it has been largely difficult to speculate and verify the mechanistic basis for the regulation 
of the RAD51 recombinase. Secondly, RAD51 is an attractive target for development of novel 
anticancer therapeutics. Of a particular value is its complex with BRCA2 tumor suppressor protein, 
whose recombination mediator activity is critical for “loading” of RAD51 onto ssDNA coated with 
ssDNA binding protein RPA. To facilitate rational design of such molecules, collaborating with 
experts in computational biology (M. Ashley Spies’ Lab, University of Iowa, MNPC), we used the 
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Saccharomyces cerevisiae Rad51 crystal structure (PDB 1SZP) as a template to build a homology 
model of Human RAD51. The model suggested previously unknown interactions between the 
RAD51 N-terminal domain and BRC4 peptide, which I was able to validate experimentally using 
biochemical assays to measure BRC4 peptide binding affinity, extension of ssDNA within RAD51 
nucleoprotein filament, and ATP hydrolysis. 
 
Using the knowledge gained from our structural model for the RAD51 recombinase, I 
developed a novel strategy to understand several key mechanisms for the regulation of RAD51 by 
phosphorylation. RAD51 is phosphorylated by the cABL tyrosine kinase at tyrosine’s 54 & 315. 
The mechanistic and functional significance of this event is largely disputed. My strategy 
employed producing RAD51 incorporating an artificial phosphomimetic (pCMF) amino acid using 
amber suppressor technology, which more accurately represents tyrosine phosphorylation on 
RAD51.  The resulting “phosphorylated” protein was analyzed using biochemical and single 
molecule assays reconstituting major activities of RAD51. Using the optimized RAD51 expression 
system, I have successfully dissected the biochemical mechanism of regulation of RAD51 by the 
c-Abl kinase. The results of my studies strongly correlate with observations made in previous cell 
based analysis which was missing until now. These studies also allowed me to propose a 
mechanism of filament nucleation and extension by the RAD51 protein. 
 
By integrating in-vivo, in-singulo and in-silico approaches, my goal is to provide a coherent 
description of how post translational modifications affect RAD51 filament formation, dynamics 
and strand exchange activities and thereby to generate insights into one of the most critical steps 
in DNA repair and to find an ‘Achilles Heel’ in RAD51 function and exploit it to develop novel 
anticancer therapies. 
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CHAPTER 2: CONTRIBUTIONS OF THE RAD51 N-TERMINAL DOMAIN TO 
BRCA2-RAD51 INTERACTION 
 
Abstract 
RAD51 DNA strand exchange protein catalyzes the central step in homologous recombination, a 
cellular process fundamentally important for accurate repair of damaged chromosomes, 
preservation of the genetic integrity, restart of collapsed replication forks and telomere 
maintenance. BRCA2 protein, a product of the breast cancer susceptibility gene, is a key 
recombination mediator which interacts with RAD51 and facilitates RAD51 nucleoprotein 
filament formation on ssDNA generated at the sites of DNA damage. An accurate atomistic level 
description of this interaction, however, is limited to a partial crystal structure of the RAD51 core 
fused to BRC4 peptide. Here, by integrating homology modeling and molecular dynamics we 
generated a structure of the full-length RAD51 in the complex with BRC4 peptide. Our model 
predicted previously unknown hydrogen bonding patterns involving the N-terminal domain of 
RAD51. These interactions guide positioning of the BRC4 peptide within a cavity between the 
core and the N-terminal domains; the peptide binding separates the two domains and restricts 
internal dynamics of RAD51 protomers. The model’s depiction of the RAD51-BRC4 complex was 
validated by free energy calculations and in vitro functional analysis of rationally designed 
mutants. All generated mutants, RAD51E42A, RAD51E59A and RAD51E237A maintained basic 
biochemical activities of the wild type RAD51, but displayed reduced affinities for the BRC4 
peptide. Strong correlation between the calculated and experimental binding energies confirmed 
the predicted structure of the RAD51-BRC4 complex and highlighted the importance of RAD51 
N-terminal domain in RAD51-BRCA2 interaction.  
_________________________________ 
This chapter appeared in its entirety in the journal Nucleic Acids Research and is referred to later in this dissertation   as 
“Subramanyam et al., 2013”. Subramanyam S, Jones WT, Spies M, & Spies MA (2013) Contributions of the RAD51 N-terminal 
domain to BRCA2-RAD51 interaction. Nucleic acids research 41(19):9020-9032. This article is reprinted with the permission of 
the publisher and is available from http://nar.oxfordjournals.org using DOI: 10.1093/nar/gkt691. 
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Introduction 
Human RAD51 and BRCA2 proteins are the key contributors to genomic integrity and are of a 
paramount importance to the cell. The intricate choreography of molecular events orchestrated by 
these two proteins ensures accurate and timely progression of homologous recombination (HR) 
(Amunugama et al., 2012a; Holloman, 2011) and has an important additional function at the 
replication fork (reviewed in (Costanzo, 2011)). HR repairs genotoxic DNA lesions via precisely 
coordinated DNA transactions that lead to exchange of information between two homologous 
DNA molecules (Li and Heyer, 2008b) and play a prominent role in faithful duplication of the 
genome (Li and Heyer, 2008b) and telomere maintenance (Oganesian and Karlseder, 2011). DNA 
Repair by HR depends on assembly of the RAD51 recombinase into a continuous nucleoprotein 
filament on ssDNA generated at the site of damage or collapsed replication (Ciccia and Elledge, 
2010; Holthausen et al., 2011; Li and Heyer, 2008b; Moynahan and Jasin, 2010). Once formed, 
the nucleoprotein filament sequesters template dsDNA, searches for homology and exchanges 
DNA strands, forming joints between recombining molecules. Assembly of the RAD51 filament 
is tightly regulated and requires assistance from a recombination mediator.  The 3148 amino acid 
(aa) BRCA2 is a tumor suppressor protein which mediates HR by recruiting RAD51 to sites of the 
DNA double strand breaks (DSBs) and facilitates loading of the RAD51 protein onto resected 
single stranded DNA (ssDNA) coated with RPA ssDNA binding protein. Once formed, the pre-
synaptic RAD51 nucleoprotein filament promotes homology search and the DNA strand exchange 
reaction (Holloman, 2011; Jensen et al., 2010; Liu et al., 2010a; Thorslund et al., 2010a). Mutations 
in human BRCA2 protein predispose to breast and ovarian cancers, and increase susceptibility to 
other tumorigenic conditions (Nathanson et al., 2001; Turner et al., 2004).  
BRCA2 interacts with RAD51 through a series of eight motifs called BRC repeats and a 
separate binding site located in the C-terminal region (Chen et al., 1998; Heyer et al., 2010; 
Holloman, 2011; Moynahan and Jasin, 2010). The highly conserved BRC repeats, approximately 
35 amino acids in length, are variably spaced in a segment of the protein encoded in exon 11 of 
the BRCA2 gene (Bignell et al., 1997; Bork et al., 1996).  Although all BRC repeats of BRCA2 
promote RAD51 nucleoprotein formation, the modes of their interaction are split among two 
classes based upon their affinities for RAD51 versus the RAD51 ̶ ssDNA filament (Carreira and 
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Kowalczykowski, 2011). Among eight BRC repeats involved in RAD51 binding, BRC4 displays 
the highest affinity for RAD51 (Carreira and Kowalczykowski, 2011). 
The interaction between BRC peptides and RAD51 family proteins likely represents a 
universal means of regulating (positively or negatively) the recombinase assembly and activity. A 
variant of BRC motif recently found in RECQL5 helicase plays a critical role in its anti-
recombinogenic activity (Islam et al., 2012), whereas loading of bacterial RecA recombinase on 
the ssDNA by RecBCD helicase/nuclease involves interaction with the structural elements on the 
RecA/RAD51 core also critical for BRC4-RAD51 interaction (Spies and Kowalczykowski, 2006). 
While the interaction between BRCA2 and RAD51 is of a paramount importance, its structural 
understanding is limited to the crystal structure of the core domain of RAD51 fused to the BRC4 
peptide (Pellegrini et al., 2002). The structure features two areas of hydrophobic interactions 
involving F1524 and F1546 of the BRCA2 and the core of RAD51 and has been exploited in 
design of the peptide inhibitors of BRC4-RAD51 interaction (Nomme et al.) and, more recently, 
in the identification of low-molecular-weight fragments that display mM affinity with a goal of 
utilizing them in the fragment-based approach (Scott et al., 2013). As only the core of RAD51 is 
present in the structure, potential involvement of the missing N-terminal domain (NTD) is unclear.  
Here, we combined homology modeling and molecular dynamics (MD) simulations to 
build an accurate atomistic description of the full length RAD51 protein in complex with the BRC4 
peptide. Our computational studies predicted previously unknown interactions between BRC4 
peptide and the RAD51 N-terminal domain. Moreover, the structure and the position of the NTD 
differed significantly from that of the yeast Rad51 (Conway et al., 2004) used as a template for 
our model. The model’s rendition of the complex was validated by in silico binding studies and 
free energy calculations, and in vitro by the functional analysis of mutants designed based on the 
results of the computational studies.  
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Results 
RAD51 Homology Model and BRC4 peptide placement 
Saccharomyces cerevisiae Rad51 structure (PDB ID: 1SZP) (Conway et al., 2004) was used as a 
template to build a homology model of two adjacent protomers within human RAD51 filament 
(Figure 2.1).  
Following all atom MD simulations with the knowledge-based force field, YASARA, 
approximately 60% of the RAD51 model (chain B) overlapped with the yeast Rad51 (1SZP-B) 
with the average RMSD between Cα atoms under 1.23 Å. Several parts of the structure, however, 
deviated significantly between the yeast and human proteins (Figure 2.2) and therefore were not 
recognized by the alignment algorithm, MUSTANG, which was used for the structure comparison 
and has a cutoff of 3.75 Å for the structurally similar residues to be matched (Konagurthu et al., 
2006). The most profound difference between the two structures involved the linker region 
between the NTD and the conserved core domain (Figures 2.2A and 2.3A), which in the yeast 
Rad51 consists of two alpha helices connected by a flexible loop, while the N-terminal domain of 
human RAD51 is connected to the core by a long rigid helix. Although the overall 4 helix bundle 
structure of the N-terminal domain is preserved in the human protein, two of these helices display 
a slightly different orientation. Note that these differences in the NTD and the linker region affect 
mainly chain B of RAD51 model whose NTD is located near the protomer-protomer interface. 
Structural change in the linker region and NTD also affected the overall orientation of the N 
terminal domain resulting in the wider cavity between the NTD and the core, which in RAD51 
accommodates BRC4 peptide after a relatively small conformational change (Figure 2.1C-F; 
Figure 2.2C; Figure 2.3C shows structural overlap between the peptide-free and the peptide bound 
RAD51). Notably, we observed a remarkable overlap between our model and the crystal structure 
of the core RAD51 (1N0W), fused to BRC4 peptide of BRCA2 (Pellegrini et al., 2002), which 
was not used in the model construction. Most of the structure (1N0W) overlapped with the 
homology model to yield an RMSD under 1Å, with exception of flexible areas around the DNA 
binding loops, and several residues preceding the Walker A box. The overall RMSD for Cα atoms 
was 1.22 Å (Figures 2.2B and 2.3B). This provides valuable orthogonal information on the quality 
of the model as 1N0W was not used to construct the homology model. The convergence between 
our model and 1N0W RAD51 core structure is especially remarkable since these two structures 
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share higher similarity than that observed between our modeled RAD51 and the structure of the 
yeast protein, which was used as a template to build the model.  
Our RAD51 model scored very well on a number of physical metrics. The Z-score, which 
evaluates the homology model for a set of physical parameters such as 3D packing, bond lengths, 
bond angles, etc (Krieger et al., 2009), after MD was -0.89, which means that the normality of 3D- 
and 1D-packing, as well as Ramachandran coordinates are less than 1 standard deviation from the 
gold standards from high-resolution crystal structures (Krieger et al., 2009). Many other checks 
were also performed to ensure normality, including normality of van der Waals and Columbic 
energies = 0.557; planarity of peptide bonds = -0.215; normality of dihedral bonds = 0.08; 
normality of bond angles = 0.291; normality of bond lengths = 0.48; normality of water positions 
= -0.392; isomers = zero wrong isomers. 
The placement of the BRC4 peptide in the RAD51 model was a critical step as the 
previously published crystal structure of RAD51 core in complex with BRC4 peptide had the 
peptide fused to the RAD51 core domain via a flexible linker (Pellegrini et al., 2002). This posed 
some uncertainty with regard to the native complex in solution, and how it should be represented 
in MD simulations. Furthermore, absence of the NTD of RAD51 from the crystal structure allowed 
BRC4 peptide to partially occupy the spatial domain that should be occluded by the NTD.  
First, we placed the peptide in the chain B. Due to the inherent flexibility of the peptide, 
an exhaustive conformational search was performed using LowMode MD while keeping the 
protein coordinates static. LowMode MD is an accelerated MD method allowing configurational 
searches outside of the usually restrictive classical MD time scales, concentrating the kinetic 
energy on low frequency vibrational modes (see methods) (Labute, 2010). 
Finally, simulated annealing energy minimization and MD was performed with the 
YASARA knowledge-based force field (KBFF), as described above, (see methods) (Krieger et al., 
2009). The second peptide was placed in the chain A by structural superposition of the subunit A 
of the homology model and the peptide, followed by simulated annealing energy minimization, as 
described in the MD methods section. Thus we obtained a system of two monomers, each with a 
bound peptide. The motivation for placing the second peptide was to provide a greater degree of 
structural similarity to a multimeric system. Only the first peptide (placed in the chain B), which 
23 
 
interfaces with a structurally complete binding site was used in the free energy calculations and 
pocket analysis, and yielded insights that guided the experimental part of this study. Notably, the 
overall structure and position of this BRC4 peptide in the homology model was remarkably similar 
to that observed in the crystal structure (Figure 2.3B). This was primarily achieved through a slight 
movement of the RAD51 NTD relative to the peptide free model (Figures 2.2C and 2.3C). 
 
Model of the RAD51-BRC4 complex predicts that both the core and NTD of RAD51 
participate in the peptide positioning 
Some structural rearrangements within RAD51 model were necessary to accommodate the BRC4 
peptide (Figure 2.1C-F, Figure 2.2C & 2.3C), which primarily involved movement of the NTD 
and the DNA binding loops. The average RMSD between Cα atoms of the RAD51 core in the 
absence and presence of the peptide were 2 Å, while the average RMSD between Cα atoms of the 
NTDs were 4.9 Å. The NTD and the RAD51 core formed a cleft, which accommodates the C-
terminal part of the BRC4 peptide (Figure 2.4A). 
Several previously unknown interactions were predicted between RAD51 and the BRC4 
peptide (Figure 2.4A). Notably, while most of these interactions involved the RAD51 monomer to 
which the peptide is placed (chain B), the model reveals additional contacts between BRC4 peptide 
and the adjacent monomer (chain A). The carboxylate of E237 defines the turn between the dsDNA 
binding Loop 1 and the N-terminus of α-helix 5 (in the nomenclature from (Pellegrini et al., 2002)), 
by receiving a hydrogen bond from the backbone amide of S233. This feature results in the -
hydroxyl of S233 pointing into the peptide binding pocket and acting as a hydrogen bond donor 
for the backbone carbonyl of E1548 and a hydrogen bond recipient of the backbone amide of this 
same residue. Simulations of the E237A mutant showed that the turn region of the adjacent 
monomer became less defined than the wild-type, resulting in the S233 group pointing away from 
the peptide binding cavity, and thus contributing to a decrease in the peptide binding free energy. 
The N-terminal domain of RAD51 participates in the interaction as well:  the carboxylate 
of E59 forms hydrogen bonds with the amide of N1544 and the amide of K1549 on the BRC4 
peptide; the amide of K1543 bonds with the backbone carbonyls of A44 and E42. Within the same 
region, E42 interacts through hydrogen bonding with S26 which in turn stabilizes the secondary 
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structure of the RAD51 N-terminal domain (Figure 2.4A).  The average distance between the 
heteroatoms involved in these hydrogen bonds consistently remained below 3Å over the course of 
a 3ns MD simulation (Figure 2.4B).  
In silico mutagenesis of three key glutamates (E42, E59 and E237) suggested their 
importance for correct positioning of the BRC4 peptide and predicted a network of interactions 
that the RAD51 NTD contributes toward the stable binding of the BRC4 peptide to RAD51 protein 
(Figure 2.4). MD simulations of RAD51 E42A and E237A mutants were used to analyze 
disruption of the hydrogen bonding interactions mentioned earlier. As expected, the distances 
between the involved heteroatoms increased markedly after the 4ns MD of the mutants. Simulation 
results for E42A showed that the only hydrogen bonding partners left for K1543 are L41 and A42 
backbone carbonyls, with heteroatom distance of ~ 3.0 A; this is substantially different than the 
wild-type hydrogen bonding pattern in which every available hydrogen of the -nitrogen of K1543 
is engaged in hydrogen bonding: 2.8 Å to carbonyl of A44, 2.8 Å to carbonyl of E42 and 3.0 Å to 
carbonyl of F46. Therefore, both E237A and E42A mutants yield predictable decreases in binding 
affinities toward the BRC4 peptide and predict a series of collective interactions that the RAD51 
NTD contributes toward the stable binding of the BRC4 peptide to RAD51 protein (Figure 2.4A). 
These observations also suggested the mutant candidates for in vitro analysis of the contributions 
of the RAD51 NTD as well as for validation of our homology model.  
   
RAD51 mutants retained structure and basic biochemical properties of the wild type protein 
Based on the predictions from the model, alanine mutants of three residues E42, E59 and E237 
were constructed, purified and analyzed to validate the role of these residues in the RAD51-BRC4 
complex (Figures 2.5 and 2.6). If our model is sound, these amino acids should display reduced 
affinities toward BRC4 peptide without perturbing other biochemical activities and properties of 
RAD51. E237A was used to indirectly study the effect of S233 which is located in the dsDNA 
binding loop (L1) and may be critical for RAD51 function.   
Analysis by circular dichroism spectroscopy confirmed that the three mutants maintained the 
secondary structure contents characteristic of wild type RAD51 (Figure 2.5C & D).  
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Formation of the recombination competent RAD51 nucleoprotein filament causes ~1.5 fold 
ssDNA extension over the B-form. Such filaments contain one RAD51 monomer per 3 nucleotides 
of ssDNA and can be formed in the presence of ATP and Ca2+ ions (Bugreev and Mazin, 2004; 
Ristic et al., 2005). Both DNA extension and binding stoichiometry are indicators of the active 
nucleoprotein filament formation. DNA binding and extension activity was measured using a 
FRET based assay wherein, we observed and quantified the RAD51-mediated extension of a 60-
mer ssDNA substrate labeled with the FRET donor (Cy3) and acceptor (Cy5) fluorophores 
separated by 25 nucleotides (Grimme et al., 2010; Grimme and Spies, 2011; Masuda-Ozawa et al., 
2013). Under the stoichiometric binding conditions, RAD51 titration results in gradual FRET 
decrease due to the spatial separation of the Cy3 and Cy5 fluorophores until the substrate is 
saturated with RAD51 and no further extension can be achieved. The inflection point in the 
titration curve reports on the binding stoichiometry, while the amplitude of the FRET decrease 
reports on the DNA extension (see methods). Similar to the wild type RAD51, all three mutants 
showed capacity to bind and extend DNA (Figure 2.6A) with the characteristic ~1:3 
protein:nucleotide binding stoichiometries.  
RAD51 is a DNA-dependent ATPase (Bugreev and Mazin, 2004). ATP hydrolysis plays a 
role in the nucleoprotein filament dynamics and in particular in the protein turnover (Amunugama 
et al., 2012b; Bugreev and Mazin, 2004; Tombline and Fishel, 2002). E42A and E59A mutants 
hydrolyzed ATP similar to wild type RAD51 with kcat values of 0.26±0.01 min
-1, 0.27±0.01 min-1 
and 0.27±0.01 min-1 (mean ± standard error) for the E42A, E59A and wild type respectively. 
E237A mutant had a slightly slower rate of ATP hydrolysis with kcat of 0.13±0.02 min
-1 (Figure 
2.6B). This was still within the range previously reported for human RAD51 (Tombline and Fishel, 
2002). Moreover, since the mutant was able to form an extended nucleoprotein filament, E237A 
substitution likely affects ATP hydrolysis, but not ATP binding resulting in a more stable filament 
and lower protein turnover.  
 
RAD51 Mutants display reduced affinity for BRC4 
Since the three mutants retained structure and biochemical activities of the wild type RAD51, they 
can be directly compared for their ability to bind BRC4 peptide. Fluorescence Polarization 
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Anisotropy (FPA) was used to characterize binding of RAD51 mutants to the BRC4 peptide. 
Protein was incrementally titrated into buffer containing FITC-labeled BRC4 peptide. Increase in 
FPA reflected RAD51-BRC4 complex formation (LiCata and Wowor, 2008). In the presence of 
ATP, RAD51 bound BRC4 peptide with Kd of 33.6 ± 6.9nM. As expected, all alanine mutants 
displayed reduced affinity for BRC4 peptide and bound with Kd values of 174 ± 31nM, 959 ± 
274nM and 560 ± 131nM for E42A, E59A and E237A mutants respectively (Figure 2.7). The 
magnitude of the change in the FPA signal reflects the size of the complex containing fluorescence 
peptide. The E59A and E237A mutants displayed higher FPA changes compared to the wild type 
RAD51 and the E42 mutant. This is likely due to binding of higher RAD51 oligomeric species to 
BRC4 and highlights importance of the contacts between the C-terminal end of BRC peptide and 
both adjacent monomers.  
 
Correlation between in silico and in vitro results reaffirm the role of RAD51 N-terminal 
domain  
Endpoint free energy calculations were used to determine the relative ΔGbinding for peptide binding 
to RAD51, and were measured over the final 3 ns of the MD simulations, after an initial 1 ns pre-
equilibration period (see Methods section). These binding endpoint free energy calculations 
exclude a number of terms such as ligand and receptor binding entropies and the nonpolar 
interactions with solvent (i.e., cavitation and van der Waals interaction with solvent). Furthermore, 
the use of an implicit solvent model to calculate the changes in the solvation energies necessitates 
the use of a uniform dielectric constant, which strongly affects the magnitude of the calculated 
binding energy. However, such endpoint free energy calculations have been useful in accessing 
the relative changes in binding free energy (Brown and Muchmore, 2009; Shirts et al., 2010; 
Steinbrecher and Labahn, 2010).   
The ΔGbind trajectories for each protein (Figure 2.8A) were analyzed and converted into 
frequency histograms to yield the distributions of ΔGbind values over the course of MD simulation 
(Figure 2.8B). These representations allow following small, but discernible differences in the 
computed binding energies. Relative ΔGbind values derived from these distributions were compared 
to the respective relative ΔG values calculated from experimentally derived Kds. All three mutants, 
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E42A, E59A and E237A, showed average changes in ΔGbind rank-ordered similarly to the 
experimentally derived values. The changes in computational binding energies correlate extremely 
well with free energy changes obtained empirically with an R value of 0.964 (Figure 2.9). An 
agreement between relative changes in free energy of binding validates the protein-peptide 
interface of the homology model and the contributions of the RAD51 NTD toward BRC4 peptide 
binding. 
 
Discussion 
Proteins and enzymes orchestrating key steps in DNA repair are emerging as promising new 
targets in anticancer drug discovery, with RAD51 being one of the most attractive targets. Crucial 
for maintenance of genomic integrity in normal cells, RAD51 allows the transformed or cancerous 
cells to develop resistance to radiation and DNA-damaging drugs used in chemotherapy. Elevated 
levels of RAD51 lead to rapid accumulation of genetic variation, genomic instability, acquisition 
of invasiveness, drug and radiation resistance and disease progression in many cancers including 
Barrett’s adenocarcenoma (Pal et al.), multiple myeloma (Shammas et al., 2009), recurrence of 
chronic myeloid leukemia (Slupianek et al., 2011), high grade gliomas (Short et al., 2011),  and 
lung cancer (Qiao et al., 2005). Targeting RAD51 may therefore allow chemo- and radio-
sensitization of cancerous cells as an adjuvant in standard combination anticancer regimens 
(Huang et al., 2012). 
Several recent HTS campaigns and rational design of inhibitors/effectors of RAD51 were 
only mildly successful yielding an inhibitor of unknown mode of action with IC50 of 27.4 µM and 
poor drug-like properties (logP = 5 and low ligand efficiency of -0.23 kcal/heavy atom) (Huang et 
al., 2011); a small molecule that mildly stimulated RAD51-mediated strand exchange activity 
(Jayathilaka et al., 2008); DNA aptamers (Martinez et al.); peptide inhibitors (Nomme et al.) and 
most recently, an inhibitor of RAD51 filament formation that covalently binds to the RAD51 
(Budke et al., 2012).  
Whereas the overall extended filamentous structure and DNA strand exchange function is 
highly conserved within the RecA/RAD51 family of recombinases, the important features of their 
structures and mechanisms differ between species. Understanding of the RAD51 structure within 
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the dynamic nucleoprotein filament may greatly facilitate rational discovery of small-molecule 
scaffolds, which can be developed into potentially effective anticancer treatments and highly 
specific molecular probes. It also will improve our understanding of the mechanisms by which the 
recombination mediators and anti-recombinases affect RAD51 interaction with ssDNA and 
dsDNA, nucleoprotein filament assembly, disassembly and dynamics.  
The existing high resolution structure of the RAD51 core fused to the BRC4 peptide of 
BRCA2 tumor suppressor protein identified several key contacts between the two proteins, 
suggested the determinants of BRC4 peptide affinity for RAD51 and the mechanism by which it 
may affect the nucleoprotein filament (Pellegrini et al., 2002). The identified contact areas on the 
RAD51 core surface, however, display poor druggability due to a featureless interaction surface 
(Surade and Blundell, 2012) with only small pockets that bind phenylalanine (Scott et al., 2013). 
In contrast, the interface between the two adjacent RAD51 monomers within the filament and the 
cleft between the NTD and the RAD51 core may contain numerous loci that can be targeted.  
Here, we report a model of RAD51, which includes both the NTD and the conserved core. 
Four ns MD simulations with knowledge based force field were employed to relax the RAD51 
model to a stable form, whose core was similar to the structure of yeast Rad51 gain of function 
mutant (PDB ID: 1SZP) used as a template. More remarkably, the post-MD model converged with 
the structure of the RAD51 core (PDB ID: 1N0W) which was not used in the model building.  
The presence of the two monomers in the model allowed us to realistically represent the 
monomer-monomer interface within the RAD51 filament as well as the position of the NTD of 
one of the monomers (chain B). Our model also predicted interactions between BRC4 peptide and 
the two RAD51 monomers adjacent in the filament. It, therefore, represents the initial stage of the 
RAD51-BRCA2 complex formation where the interface between adjacent monomers of RAD51 
is slightly perturbed, but not yet completely abolished and replaced by the interactions with N-
terminal part of the BRC4 peptide. While the BRC4 peptides were placed in both monomers, 
contacts made by only one peptide placed in the chain B and contacting the monomer-monomer 
interface were evaluated. The backbone of the BRC4 peptide in our model overlapped well with 
the peptide in the 1N0W structure; the orientations of several side chains, however, were different 
reflecting their interactions with the NTD and the adjacent monomer. This was somewhat expected 
since the position of the peptide in the crystal structure might have been constrained by fusion of 
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the peptide to the RAD51 core and by extraordinary dense crystal packing. In our model, on the 
other hand, the NTD partially overlapped with the space occupied by the peptide in the crystal 
structure. Modeling of the RAD51-BRC4 complex suggested that the largest deviation between 
the RAD51 structures with and without the BRC4 peptide will involve movement of the NTD 
(Figure 2.1C&D, Figures 2.2C and 2.3C).  
To confirm the validity of the model we identified several previously unknown contacts 
between the BRC4 peptide and RAD51. In particular, we focused on the contacts that involved the 
NTD or the adjacent RAD51 monomer. The binding energy calculations of the BRC4 complexes 
with the 3 RAD51 glutamate to alanine mutants carried out over 4 ns MD simulations suggested 
that the three following mutants E42A, E59A, and E237A should display compromised affinities 
for the BRC4 peptide, but retain the biochemical properties of the wild type RAD51. Indeed the 
three purified mutants had lower than the wild type affinity for the BRC4 peptide with the rank 
order predicted by the binding energy calculations. While the contributions from each of the 
identified residues to the overall energy of the RAD51-BRC4 complex formation are relatively 
modest, as expected for the hydrogen bond disruptions in a protein-peptide contact surface, 
collectively they highlight the importance of the NTD of RAD51 in the BRC4 positioning and 
suggest the mechanism by which the interaction between BRC4 peptide and the adjacent monomer 
within the RAD51 oligomer contributes to the RAD51 oligomer destabilization and selectivity for 
ssDNA.  
We envision that the interaction between K1543 of the BRC4 and E42 and A44 of the NTD 
(Figure 2.4) guide the peptide into the cleft between NTD and the RAD51 core and simultaneously 
shift the position of the NTD (Figure 2.1 C & D, Figures 2.2C and 2.3C). This allows placement 
of the F1546 of the peptide in the hydrophobic pocket within the RAD51 core revealed by the 
crystal structure. Two hydrogen bonds accepted by E59 from N1544 and K1549 further stabilize 
the peptide in the cleft between the NTD and the RAD51 core. The peptide then interacts with the 
S233, which belongs to the Loop1 (dsDNA binding loop) of the adjacent RAD51 monomer. This 
interaction may constrain the dsDNA binding and at least in part be responsible for enforcing 
selectivity of the RAD51-BRCA2 for ssDNA over dsDNA. Together with the interaction between 
E1548 of the BRC4 and R250 observed both in the 1N0W structure and in our model, the S233-
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BRC4 interaction may also affect relative orientation of the two adjacent RAD51 monomers and 
thereby destabilize the monomer-monomer interface.  
Another notable interaction is the hydrogen bond between Q1551 of the peptide and P56 
within the NTD of RAD51. This interaction positions the C-terminus of the BRC4 peptide near 
the N terminus of the peptide docked in the second monomer.  
The difference between the yeast and human RAD51 proteins in the position and structure 
of the NTD provides a glimpse into co-evolution of the recombinase and recombination mediator. 
The more rigid connector between the two domains of human RAD51 shifts the position of NTD 
relative to the core and creates the binding site that has enough flexibility to accommodate diverse 
BRC peptides.    
 
Materials and Methods 
RAD51 Homology Model 
The crystal structure of yeast Rad51 gain of function mutant (PDB ID: 1SZP, (Conway et al., 
2004)) representing an active conformation of the Rad51 filament was used to build a homology 
model of two RAD51 monomers adjacent in the nucleoprotein filament. The model was 
constructed using The Chemical Computing Group’s Molecular Operating Environment (MOE) 
(Molecular Operating Environment (MOE) 2010.09, 2012). Ten intermediate homology models 
resulting from permutational selection of different loop candidates and side chain rotamers were 
built for RAD51, each subjected to a degree of energy minimization using the force field 
MMFF94x, with a distance-dependent dielectric. The model of the monomer (chain B) was 
constructed in the presence of the adjacent monomer in the 1SZP-A template, in order to optimize 
the monomer-monomer interface. The intermediate model which scored best according to the 
packing evaluation function was chosen for the next level of refinement: the RAD51 dimer was 
constructed by superposition of the RAD51 homology modeled monomer onto the 1SZP dimer 
crystal structure, followed by simulated annealing energy minimization and 4 ns MD simulations 
with the knowledge-based YASARA force field (see below). 
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The Mg-ATP substrate was placed by first building and then docking with flexible ligand 
docking into a region that corresponds to the canonical ATP binding site of the E. coli RecA protein 
(PDB ID: 1XMS, (Xing and Bell, 2004)). The AutoDock implementation in YASARA Structure 
was employed. AutoDock 4 employs a Lamarckian genetic algorithm to sample ligand 
conformations and binding modes. It uses a semi-empirical free energy force field to predict free 
energies of binding which accounts for intermolecular and intramolecular energies, as well as 
charge-based desolvation. The following general docking parameters were used: 25 independent 
docking runs, each with a total of 2.5 x 106 energy evaluations, a torsional degrees of freedom 
value of 8, grid point spacing was left at the default of 0.375 Å, and the force field selected was 
AMBER03. Specific to the genetic algorithm, the following parameters were used: a population 
size of 150, 2.7 x 104 generations, an elitism value of 1, a mutation rate of 0.02, and a crossover 
rate of 0.8. Final poses were considered distinct if they varied by > 5 Å RMSD. All atom energy 
minimization was then performed on the docked structure. This represented a starting point for 
MD simulations, and no constraints were placed on the Mg-ATP. 
 
Placement and Conformational Search of BRCA4 Peptide 
The partial structure of human Rad51 with BRACA4 peptide (PDB 1N0W) was superposed onto 
the dimer Rad51 homology model using the superpose utility of MOE, in order to initially place 
the BRACA4 peptide at the interface of the two monomers. The complex was then subjected to a 
specialized stochastic conformational search protocol called LowModeMD (Labute, 2010) within 
the MOE package. This method concentrates kinetic energy on low-frequency vibrational modes, 
in order to populate conformations in multiple low-energy states with high computational 
efficiency, and is particularly appropriate for complex systems with large numbers of nonbonded 
interactions, such as peptides, peptide loops and macrocyles. The LowModeMD conformational 
search procedure includes an iterative process of initial energy minimization, filtering of high 
frequency vibrational modes, a short (~0.5 ps) MD and saving distinct structures in a database. 
The energy minimization gradient threshold was 0.001 kcal/mol/Å, and searches were configured 
to terminate after 200 contiguous failed attempts to generate novel conformations, with up to 
10,000 iterations. Conformations were identified as unique if their root-mean-square-distance was 
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above a threshold value of 0.75 Å. RAD51 protein remained frozen throughout the LowModeMD 
conformational search, and a single low-energy peptide conformation was identified.  
 
Classical MD Simulations with two Adjacent RAD51 Monomers  
The molecular dynamics simulations on the homology model of RAD51 containing ATP and in 
the presence and absence of BRC4 peptide were performed with the YASARA Structure package 
version 12.4.1 (YASARA Biosciences) (Krieger). A periodic simulation cell with dimensions 
104.94 Å, 73.68 Å, and 78.23 Å was used with explicit solvent. The YASARA KBFF was used 
with long-range electrostatic potentials calculated with the Particle Mesh Ewald (PME) method 
(Darden et al., 1993; Essmann et al., 1995), with a van der Waals cutoff of 7.864 Å. This force 
field has been highly successful for use with homology modeling and protein structure prediction, 
in that it limits the damage (i.e. drifting into structurally unrealistic protein phase space) that often 
results from energy minimization and MD using empirical force fields.  
ATP force field parameters were generated with the AutoSMILES utility (Jakalian et al., 
2002) which employs semi-empirical AM1geometry optimization and assignment of charges, 
followed by assignment of AM1BCC atom and bond types with refinement using RESP charges, 
and finally the assignments of general AMBER force field atom types. The hydrogen bond network 
of RAD51 was optimized using the method of Hooft and coworkers (Hooft et al., 1996), in order 
to address ambiguities from multiple side chain conformations and protonation states that are not 
resolved by the electron density of the template. YASARA’s pKa utility was used to assign pKa 
values at pH 7.0 (Krieger et al., 2006). The box was filled with water, with a maximum sum of all 
bumps per water of 1.0 Å, and a density of 0.997 g/ml.  The simulation cell was neutralized with 
NaCl (0.9% w/v final concentration). Excessive water molecules were deleted to readjust the 
solvent density to 0.997 g/ml.  A short MD was run on the solvent only. The entire system was 
then energy minimized using first a steepest descent minimization to remove conformational 
stress, followed by a simulated annealing minimization until convergence (<0.05 kJ/mol/200 
steps). The MD simulation was then initiated, using the NVT ensemble at 298 K, and integration 
time steps for intramolecular and intermolecular forces were calculated every 1.25 fs and 2.5 fs, 
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respectively. This procedure was conducted after each in silico mutation as well. The structural 
alignments were performed with the MUSTANG method (Konagurthu et al., 2006). 
 
Free Energy Binding Calculations with the Fast Boundary Element Method (BEM)  
The method employed here is called the Boundary Element Method (BEM) (Juffer et al., 1991; 
Zauhar et al., 1985). It falls under the class of free energy calculations known as Endpoint Methods, 
which also includes the popular MM-PBSA approach (also called the finite difference method) 
(Steinbrecher and Labahn, 2010). Endpoint Methods calculate the ∆Gbind from constituent parts of 
a thermodynamic cycle that involve solvation of the individual components. The binding energy 
expression is: 
∆𝐺𝐵𝑖𝑛𝑑,𝑆𝑜𝑙𝑣  =  ∆𝐺𝐶𝑜𝑚𝑝𝑙𝑒𝑥,𝑉𝑎𝑐𝑐𝑢𝑚  +  ∆𝐺𝐶𝑜𝑚𝑝𝑙𝑒𝑥,𝑆𝑜𝑙𝑣 − (∆𝐺𝐿𝑖𝑔𝑎𝑛𝑑,𝑆𝑜𝑙𝑣  +  ∆𝐺𝑅𝑒𝑐𝑒𝑝𝑡𝑜𝑟,𝑠𝑜𝑙𝑣 ) + ∆𝐺𝑛𝑝  
In the BEM much of the focus is placed on accurately representing the boundary between the two 
dielectrics, in which a very accurate boundary charge distribution is used to represent a uniform 
dielectric at the interface between the low and the high dielectric continuum. From this boundary 
region of uniform dielectric strength, Coulomb's Law is used to calculate the electrostatic 
potentials.  
A major difficulty in Endpoint methods is assigning an internal dielectric (Schutz and 
Warshel, 2001). Since the BRC-peptide binding cavity of RAD51 is relatively solvated, we chose 
to employ a protein dielectric ε of 13; values of 4 to 20 are routinely employed, often using mixed 
values (Ravindranathan et al., 2011; Schutz and Warshel, 2001). It is important to note that ∆Gbind 
values obtained from Endpoint methods, such as MM-PBSA or BEM, should be viewed as 
enhanced scoring functions, which have enhanced rank-ordering value, rather than as metrics of 
accurate absolute binding free energy (Sotriffer and Matter, 2011). For the current study, using 
BEM, the boundary between solvent (dielectric constant 78) and the solute (dielectric constant 13) 
was formed by the latter's molecular surface, constructed with a solvent probe radius of 1.4 Å and 
the following radii for the solute elements: polar hydrogens 0.32 Å, other hydrogens 1.017 Å, 
carbon 1.8 Å, oxygen 1.344 Å, nitrogen 1.14 Å, sulfur 2.0 Å. The solute charges were assigned 
based on the AMBER03 force field (Cornell et al., 1995). The term for the hydrophobic component 
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of peptide binding, ∆Gnp was not included in these calculations, since this value is not expected to 
change in the mutated complexes being considered. The peptide binding entropy was not included 
in the relative binding energy calculations, and is not expected to significantly contribute to this 
value. After a 1 ns equilibration period, BEM ΔGbind value was calculated every 7 ps, for duration 
of 3 ns. The ensembles of the endpoint peptide binding free energy values were obtained for the 
wild type RAD51, E42A, E59A and E237A mutants (Figure 2.8A), and transformed into the 
histograms (Figure 2.8B) using GraphPad Prism 4. 
 
RAD51 Protein Expression and Purification 
RAD51 protein was expressed in E. coli Acella™ strain in the presence of pLysSRARE and 
pChaperone (generous gift from Dr. Alex Mazin, Drexel University) plasmids in LB medium 
containing Carbenicillin (50µg/ml), Kanamycin (40µg/ml) and Chloramphenicol (34µg/ml). The 
cells were grown at 37˚C. After OD600 reached 0.6 RAD51 expression was induced with 0.1mM 
IPTG (Calbiochem). Induced cells were further incubated at 37˚C for 4 hours, pelleted by 
centrifugation and lysed by sonication in the lysis buffer containing 100mM Tris-OAc (pH 7.5), 
2mM EDTA, 10% Glycerol, 1mM DTT, Lysozyme (0.5mg/ml), 0.1% Triton X-100 and Complete, 
mini, EDTA Free Protease Inhibitor Tablets (Roche). The clarified lysate was then dialyzed 
overnight against 3 changes of 0.5 liters of 20mM Tris-OAc pH 7.5, 7mM Spermidine, 10% 
Glycerol, 0.1mM DTT. The precipitate was collected by centrifugation, re-suspended in T-75 
buffer (50mM Tris-HCl pH 7.5, 10% Glycerol, 75mM NaCl, 0.1mM DTT) and then centrifuged 
again. The Pellet and supernatant were collected and the process was repeated by re-suspending 
the pellet in T-150, T-250, T-500 and T-600 buffers (containing 150mM, 250mM, 500mM and 
600mM NaCl, respectively). Fractions containing RAD51 were pooled and loaded onto HiTrap 
Blue column equilibrated with Buffer BA (100mM Potassium Phosphate pH 7.0, 5% Glycerol, 
300mM NaCl, 1mM EDTA, 1mM DTT). Protein was eluted using a 0 – 2M NaSCN gradient and 
dialyzed overnight in Buffer HA (20mM HEPES pH 7.5, 5% Glycerol, 150mM NaCl, 1mM 
EDTA, 1mM DTT). RAD51 containing fractions were then loaded onto a Heparin column and 
protein eluted with a 150mM – 2M NaCl gradient followed by overnight dialysis in Buffer HA. 
Finally, the RAD51-containing fractions were concentrated on a MonoQ column using a steep 
150mM – 1.2M NaCl gradient elution. The purified RAD51 was then dialyzed overnight in 
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modified Buffer HA (0.1mM EDTA), aliquoted and stored at -80˚C. RAD51 concentration was 
determined using absorption at A280 with an extinction coefficient of 12800M
-1cm-1 (Baumann et 
al., 1997). Percentage of glycerol in buffers could be varied between 5% and 10%. Human RPA 
was purified as previously described (Henricksen et al., 1994).  
RAD51 E42A, E59A and E237A mutants were produced using the QuikChange II XL site-
directed mutagenesis kit (Agilent) using the following oligonucleotide primers (Supplementary 
Table S1). All mutants were purified using the protocol described for the wild type RAD51. 
 
Fluorescence Polarization Anisotropy based RAD51-BRC4 Binding Assay 
Binding affinity of RAD51 for the BRC4 peptide was measured by following fluorescence 
polarization anisotropy (FPA) of FITC labeled BRC4 peptide (LiCata and Wowor, 2008). Fifteen 
nM of FITC-BRC4 peptide (FITC-KEPTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQ) 
(Carreira et al., 2010) was incubated at 37˚C in the reaction buffer containing (20mM HEPES pH 
7.0, 2mM CaCl2, 10mM MgCl2, 1mM DTT). FITC fluorescence was measured using excitation 
and emission wavelengths of 490 nm and 518 nm, respectively using Cary Eclipse Fluorimeter. 
Experiments were carried out in the presence of 1mM ATP. Dissociation constant (Kd) was 
measured by fitting the data to the binding isotherm – 
∆A = Ao +
∆Amax {(𝐾𝑑 + [𝑅𝐴𝐷51] + [𝐵𝑅𝐶4]) − √(𝐾𝑑 + [𝑅𝐴𝐷51] + [𝐵𝑅𝐶4])2 − 4[𝑅𝐴𝐷51][𝐵𝑅𝐶4]}
2[BRC4]
 
Where ΔA is change in anisotropy, Ao is initial anisotropy in the absence of RAD51 and ΔAmax is 
maximum change in anisotropy, [RAD51] is the total RAD51 concentration at each point of the 
titration and [BRC4] is the total peptide concentration. GraphPad Prism 4 software was used for 
data analysis. 
 
Circular Dichroism Spectroscopy 
The CD spectra of 3µM of RAD51 was recorded between 190 nm and 260 nm at room temperature 
in 50 mM Potassium Borate buffer pH 8.0 using J-750 Spectropolarimeter (JASCO). The 
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secondary structure contents for the wild type and mutant RAD51 proteins  (α-helix:-
strand:Random coil ratios) were determined using the DichroWeb K2D program (Whitmore and 
Wallace, 2004). 
 
RAD51 ATPase Assay 
ATP hydrolysis activity of RAD51 was measured using coupled reactions assay (Kowalczykowski 
and Krupp, 1987). Briefly, 5µM of RAD51 was incubated with 30µM (nucleotides) Poly dT100 in 
reaction buffer (20mM HEPES pH 7.5, 6mM MgCl2, 2mM ATP, 1mM DTT, 7.5mM PEP, 
0.2mg/mL NADH, 3.6-6.0U/mL pyruvate kinase, 5.4-8.4U/mL lactate dehydrogenase) at 37˚C; 
oxidation of NADH was measured by recording decrease in absorbance at A340.  The slope of the 
absorbance change was then converted into the rate of ATP hydrolysis in µM ATP hydrolyzed per 
min per µM RAD51.  
 
DNA Binding and Extension Assay 
The ability of RAD51 to bind and extend ssDNA was measured using the FRET based assay 
described previously (Grimme and Spies, 2011). Six hundred nM (nucleotides) of dT60 oligo 
labeled with the Cy3 and Cy5 dyes separated by 25 nt was titrated with RAD51 protein in FRET 
Reaction Buffer (20mM HEPES pH 7.5, 5mM CaCl2, 5mM MgCl2, 1mM ATP, 1mM DTT) at 
37˚C.  Cy3 and Cy5 fluorescence was recorded using Cary Eclipse Fluorimeter. The FRET 
efficiency was calculated as a fraction of acceptor intensity relative to the total donor and acceptor 
intensity adjusted by correction factors as described in (Grimme and Spies, 2011).  
RAD51 ability to extend DNA beyond the contour length was evaluated by comparing to the DNA 
extension by human RPA. 
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Images 
Molecular graphics images were produced using the UCSF Chimera package from the Resource 
for Biocomputing, Visualization, and Informatics at the University of California, San Francisco 
(supported by NIH P41 RR-01081; (Pettersen et al., 2004)). 
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Figures 
 
Figure 2.1. RAD51-BRC4 model and BRC4-induced structural rearrangements in RAD51 filament. 
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Figure 2.1. RAD51-BRC4 model and BRC4-induced structural rearrangements in RAD51 
filament. A. Ribbon diagram of the homology model of two adjacent RAD51 protomers 
containing BRC4 peptides: Chain B is shown in a dark blue; chain A is in a lighter blue; the two 
peptides are shown in purple. The RAD51 DNA binding loops L1 and L2 are shown in orange and 
green, respectively, and the ATP binding region is shown in yellow. B. Schematic representation 
of the BRC4 peptide bound RAD51.  C. 𝛼 −Carbon RMSDs for the peptide-free and BRC4-bound 
RAD51 (chain B) as a function of the residue number. Letters D-F above the graph indicate the 
most divergent structural elements. The respective structural overlaps are shown in the panels D-
F: D. NTD and the linker; E. dsDNA binding Loop L1; F. ssDNA binding loop L2. 
40 
 
 
Figure 2.2. Structural comparison of the RAD51 homology model and known RAD51 and Rad51 structures. 
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Figure 2.2. Structural comparison of the RAD51 homology model and known RAD51 and 
Rad51 structures. A. 𝛼 −Cα RMSDs derived from the structural overlap between RAD51 
homology model (Chain B, no peptide) and yeast Rad51 (1SZP, Chain B). 𝛼 −Cα RMSDs for the 
most of the residues within the NTD were larger than the 3.75Å, and therefore could not be paired 
by the alignment algorithm (MUSTANG) used to compare the two structures. The inset shows 
overlap between the NTD of RAD51 (blue) and the NTD of Rad51 (green). B. 𝛼 −Cα RMSDs 
derived from the structural overlap between RAD51 homology model (chain B with BRC4 
peptide) and the RAD51 core crystal structure (1NOW). Residues of the NTD and the DNA 
binding loops were absent from the 1NOW structure and therefore could not be compared.  C. 
𝛼 −Cα RMSDs derived from the structural overlap between RAD51 homology models (chain B) 
with and without BRC4 peptide.  
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Figure 2.3. Ribbon representation of the structural overlaps that yielded RMSD values shown in Figure 2.2. 
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Figure 2.3. Ribbon representation of the structural overlaps that yielded RMSD values 
shown in Figure 2.2. A. RAD51 chain B (blue) vs. yeast Rad51 1SZP-B (green). B. RAD51 chain 
B with peptide (RAD51 is shown in blue, peptide is in purple) vs. the core RAD51 and BRC4 from 
1N0W (both are shown in white). C. RAD51 chain B with peptide (RAD51 is shown in blue, 
peptide is in purple) vs. RAD51 Chain B in the absence of the peptide (white). In all structures, 
the DNA binding loops L1 & L2 are shown in orange and green, respectively. 
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Figure 2.4. Non-obvious interactions involved in BRC4 positioning between the RAD51 core and NTD revealed by the 
model. 
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Figure 2.4. Non-obvious interactions involved in BRC4 positioning between the RAD51 core 
and NTD revealed by the model. A. Interface between RAD51 (chain B is shown in blue, chain 
A is shown in white) and BRC4 peptide (purple).  The key residues are represented in ball in stick. 
The key hydrogen bonds described in the text are shown as black lines. The colored arrows indicate 
hydrogen bonds followed over the MD simulation as shown in the panel B. B. Change in the 
distances between heteroatoms participating in the hydrogen bonds as functions of MD simulation 
time. The distances were extracted from the wild type structure (top) and E42A mutant (middle); 
comparison of the wild type and E237A (bottom). The distributions of the distances are also shown 
as histograms on the right. 
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Figure 2.5. Purified RAD51 mutants retained secondary structure of the wild type RAD51 protein. A. SDS-PAGE gel of the 
purified wild type RAD51, RAD51E42A, RAD51E59A, and RAD51E237A. B. Schematic representation of the RAD51 monomer 
showing locations of each mutant within RAD51-BRC4 complex. RAD51 is shown in blue and BRC4 peptide is in purple. C. CD 
Spectra of RAD51 Wt and alanine mutants were similar suggesting preservation of protein secondary structure. D. The secondary 
structure compositions determined using the DichroWeb K2D program. 
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Figure 2.6. RAD51 mutants retained basic biochemical activities characteristic to the wild type protein. A. Formation of the 
active RAD51 nucleoprotein filament was monitored by following extension of the 60-mer oligonucleotide poly(dT)-60 containing 
Cy3 (FRET donor) and Cy5 (FRET acceptor) fluorophores separated by 25 nucleotides. Under the selected buffer conditions, the 
protein-free DNA has a characteristic FRET value of ~0.6; the same DNA molecule extended to its counter length upon 
complexation with RPA give a FRET signal of ~0.3; 1.5 times extension of the ssDNA bound by RAD51 decreases FRET to ~0.2. 
B. The kcats for the ssDNA-dependent ATP hydrolysis by the wild-type and mutant RAD51 proteins. ATP hydrolysis was measured 
using coupled reactions assay as described in the Supplementary Methods. 
 
48 
 
 
Figure 2.7. RAD51 mutants display compromised 
affinities for BRC4 peptide. A. schematic 
representation of the FPA-based peptide binding 
assay. BRC4 peptide is shown in purple; FITC dye is 
in orange; RAD51 is in blue B. Binding isotherms 
show titration of the 15 nM BRC4 peptide with the 
indicated concentrations of the wild type and mutant 
RAD51 proteins. The Kd values are indicated by the 
respective isotherms. The error bars represent standard 
error (SEM) for three independent experiments; error 
bars are smaller than the data points where not seen. 
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Figure 2.8. Computational binding energies ΔGbind for the BRC4 interaction with wild type 
RAD51, E42A, E59A and E237A. A. ΔGbind trajectories for the BRC4 complex with each protein 
over the course of MD simulation. B. Trajectories from 34 were converted into frequency 
histograms to yield the distributions of ΔGbind values.  
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Figure 2.9. Correlation between computational and experimental relative binding free energies. Computational and 
experimental relative binding free energies show a high degree of correlation (R=0.96). This validates the protein-peptide interface 
of the RAD51-BRC4 homology model and the contributions of the RAD51 N-Terminal Domain toward BRC4 binding. 
Experimental fractional changes in binding energy were calculated from Kd values (Figure 2.7B). Computational fractional changes 
in binding energy were calculated using endpoint, boundary element method as   twtwbind GGGG .. / 
(Figure 2.8).  
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CHAPTER 3: TYROSINE PHOSPHORYLATION STIMULATES ACTIVITY OF 
HUMAN RAD51 RECOMBINASE 
 
Abstract 
The DNA strand exchange protein RAD51 facilitates the central step in homologous 
recombination, a process fundamentally important for accurate repair of damaged chromosomes, 
restart of collapsed replication forks and telomere maintenance. The c-Abl tyrosine kinase and its 
oncogenic BCR-ABL fusion phosphorylate RAD51 on tyrosine residues 54 and 315. We combined 
biochemical reconstitutions with Total Internal Reflection Fluorescence Microscopy (TIRFM) to 
determine how the two phosphorylation events affect the biochemical activities of RAD51 and 
properties of the RAD51 nucleoprotein filament. By mimicking RAD51 tyrosine phosphorylation 
using a non-natural amino acid, p-Caboxymethyl-L-Phenylalanine (pCMF) we demonstrated that 
Y54 phosphorylation enhances the RAD51 recombinase activity, modifies the RAD51 
nucleoprotein filament formation and allows RAD51 to efficiently compete with ssDNA binding 
protein RPA. In contrast, Y315 phosphorylation has little effect on the RAD51 activities. Based 
on our work and previous cellular studies we propose a mechanism underlying RAD51 activation 
by c-Abl/BCR-ABL kinases. 
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Introduction 
 
The DNA in the human genome is constantly subjected to damage. This damage is a byproduct of 
normal cellular metabolic activities, exposure to radiation and chemical mutagens present in the 
environment (Ciccia and Elledge, 2010). Homologous Recombination (HR) and the pathways that 
employ the machinery of HR are responsible for the most accurate repair of the most deleterious 
DNA lesions including double-stranded DNA breaks (DSBs), inter-strand DNA crosslinks (ICLs), 
and damaged replication forks and thereby contributes to maintenance of the stable genome 
(Couedel et al., 2004; Head, 2010; Heyer, 2015; Jasin and Rothstein, 2013b; Li and Heyer, 2008a; 
Moynahan and Jasin, 2010; Schipler and Iliakis, 2013). HR also plays an important role in telomere 
maintenance (Doksani and de Lange, 2014; Oganesian and Karlseder, 2011). HR, a process highly 
conserved throughout the evolution, is carried out through a precisely coordinated and tightly 
regulated series of events. The key step in HR is the assembly of a RecA-family recombinase 
(phage UvsX, bacterial RecA, archaeal RadA, or eukaryotic RAD51 DNA strand exchange 
protein) onto resected single stranded DNA (Symington, 2014). The recombinase forms a 
nucleoprotein filament which then invades homologous duplex DNA resulting in a displacement 
loop structure that can be used as a primer for synthesis using the intact duplex as a template (Jasin 
and Rothstein, 2013a). Similarly to its bacterial and yeast homologs, human  RAD51 binds single 
stranded DNA (ssDNA) in an ATP dependent manner (Tombline et al., 2002). The nucleoprotein 
filament formed by the ATP-bound RAD51, is arranged such that each RAD51 monomer binds 
three nucleotides, forming the pairing unit in these reactions (Lee et al., 2015). Beyond these basic 
attributes, the characteristics of RAD51 protein differs significantly from its archaeal and bacterial 
homologues. Subtle differences in ATP hydrolysis (Tombline and Fishel, 2002), DNA binding and 
nucleoprotein filament formation and extension (Holthausen et al., 2011) influence the mechanism 
by which the RecA homologs function as well as how they are regulated.  
 
The critical role of HR requires all steps of this process to be tightly regulated to avoid 
untimely or illegitimate recombination that may cause carcinogenic genome rearrangements or 
result in the cytotoxic intermediates. Inactive HR causes loss of faithful DNA repair and leads to 
53 
 
genetic instability whereas excessive HR interferes with cellular processes such as replication, 
transcription and telomere maintenance and also can lead to gross chromosomal rearrangements 
(Heyer, 2015). In human cells, the assembly of RAD51 nucleoprotein filament is aided by the 
recombination mediator BRCA2 and RAD51 paralogs (Prakash et al., 2015; Zelensky et al., 
2014b), antagonized by the antirecombinases (Daley et al., 2014b) and the heteroduplex rejection 
machinery (Spies and Fishel, 2015), and is also regulated by post translational modifications. 
Activities of RAD51 in the cell are influenced by two types of phosphorylation. RAD51 protein is 
phosphorylated at threonine residue 309 by the Chk1 checkpoint kinase (Sorensen et al., 2005) 
which regulates the DNA damage response. It is also phosphorylated at tyrosine residues 54 and 
315 by the c-Abl/BCR-ABL tyrosine kinase (Slupianek et al., 2001; Yuan et al., 1998). Ionizing 
radiation and other genotoxic agents activate c-Abl kinase in an ATM and DNA-PK dependent 
manner (Baskaran et al., 1997; Shafman et al., 1997). There have been several studies on how c-
Abl regulates RAD51 with a major debate regarding the site targeted by this tyrosine kinase. 
Recent studies suggested that RAD51 is phosphorylated in two steps with Y315 phosphorylation 
being a prerequisite for the Y54 phosphorylation (Popova et al., 2009). There remains, however, 
an uncertainty about the biochemical effects of RAD51 phosphorylation by c-Abl.  Results of the 
cell-based studies suggested that the Y54 and Y315 phosphorylation enhances the RAD51 nuclear 
foci formation and resistance to DNA damaging agents (Slupianek et al., 2001; Yuan et al., 2003). 
In contrast, biochemical studies which used aspartate and glutamate amino acids to mimic Y315 
phosphorylation, or used s. cerevisiae Rad51 (sceRad51) phosphorylated in vitro by c-Abl kinase 
showed a decrease in the DNA strand exchange activity (Takizawa et al., 2004; Yuan et al., 1998). 
The discrepancy between the results of the biochemical and cellular studies may stem from the 
fact that Saccharomyces cerevisiae lacks tyrosine phosphorylation (Lim and Pawson, 2010) and 
from a substantial structural difference between yeast and human proteins (Subramanyam et al., 
2013). Also, representation of phosphotyrosine by a negatively charged amino acid is often 
inaccurate. In fact, we have recently shown that Y/D substitution incorrectly represents tyrosine 
phosphorylation in another c-Abl target, human RAD52 (Honda et al., 2011).  
Our studies aim to provide a mechanistic model that reconciles biochemical data with that 
observed in the cell-based studies and to identify the properties of RAD51 protein and its 
nucleoprotein filament that are altered to enhance or diminish HR. By incorporating a non-natural 
amino acid that accurately mimics phosphorylated tyrosine residues, we provide a realistic 
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representation of the phosphorylated RAD51. Moreover, the impact of the two individual 
phosphorylation events can be easily distinguished. Our model of human RAD51 (Subramanyam 
et al., 2013) predicted that Y54 participates in the inter-subunit stacking interaction with F195 of 
the adjacent monomer within the RAD51 filament similar to the interaction revealed in sceRad51 
structure (Conway et al., 2004) (Figure 3.1A). Introduction of a large negative charge by Y54 
phosphorylation is expected to break the stacking and may alter the RAD51-RAD51 interface. 
Even slight deviations towards either a more or a less stable RAD51 filament due to this alteration 
may have significant effect of the RAD51 nucleoprotein filament assembly and function. Y315 is 
also near the RAD51-RAD51 interface and is directly adjacent to D316, which was proposed to 
form a salt-bridge to the γ-phosphate of ATP and to function as a conformational sensor that 
enhances nucleoprotein filament turnover (Amunugama et al., 2012b). It is more difficult to 
anticipate the effect of placing an additional negative charge next to this charged aspartate. 
Using biochemical assays that report on the recombinase function of phosphomimetic 
RAD51, we observed elevated DNA strand exchange activity of Y54-phosphomimetic 
(RAD51Y54pCMF), but not the Y-315-phosphomimetic protein (RAD51Y315pCMF) consistent with 
previously published cellular studies that reported the enhanced HR and RAD51 localization at the 
sites of the DNA damage (Shimizu et al., 2009; Slupianek et al., 2001). Moreover, we showed that 
RAD51Y54pCMF can efficiently carry out the so-called “RPA-first” DNA strand exchange reactions 
that would normally require the presence of a recombination mediator. To elaborate on the 
mechanism of RAD51 function and regulation, we employed Forster Resonance Energy Transfer 
(FRET) based experiments at ensemble and single molecule levels. Analyzing single molecule 
data by Hidden Markov Modeling (HMM’s), we showed differences in DNA binding on 
phosphorylation that explain the basis of nucleoprotein filament formation and robust DNA strand 
exchange activity of RAD51Y54pCMF. Finally, we provide a model for the regulation of the RAD51 
protein by sequential phosphorylation, highlighting the mechanism of regulation by the c-
Abl/BCR-ABL kinases. 
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Results 
 
Mimetics of the RAD51 Y54 and Y315 Phosphorylation 
Protein phosphorylation is commonly mimicked by charged amino acids Aspartate (D) and 
Glutamate (E). These substitutions may inaccurately represent phosphotyrosine when the precise 
geometries or the aromatic ring of the tyrosine are important (Honda et al., 2011; Xie et al., 2007).   
For a more accurate representation of the effects of tyrosine phosphorylation on RAD51, we used 
a non-natural amino acid, p-carboxmethyl-L-phenylalanine (pCMF), which mimics all aspects of 
a phosphorylated tyrosine residue (Figure 3.1B) (Honda et al., 2011; Xie et al., 2007). 
RAD51Y54pCMF and RAD51Y315pCMF mutants were produced using expression in E. coli Acella™ 
Cells transformed with the pCH1-RAD51 vector (see methods), along with the pSUPT-UaaRS 
vector encoding the amber tRNA and pCMF-RS (Figure 3.2). Induction of the cells in the presence 
of IPTG produced large amounts of truncated proteins which could easily be distinguished from 
the full length protein which was expressed in the presence of pCMF (Figure 3.1C, D & E). The 
uniform incorporation of the amino acid for both RAD51Y54pCMF and RAD51Y315pCMF mutants was 
confirmed through western blot analysis using α-RAD51 (3C10) antibodies (Figure 3.1D) and by 
MALDITOF-MS as a ~42Da increase in molecular weight (Figure 3.2). Protein yields were around 
20% compared to the wild type RAD51 expression owing to loss to insoluble fractions and 
truncated products. Mutants replacing the RAD51 Y54 and Y315 residues with Aspartate (D), 
Glutamate (E) and phenylalanine (F) residues were also purified (Figure 3.2) to illustrate the 
differences between these and the pCMF mutants. 
 
Tyrosine 54 Phosphorylation stimulates RAD51 DNA Strand Exchange activity 
A critical HR function of the RAD51 nucleoprotein filament is to perform an ATP-
dependent homologous DNA pairing and the DNA strand exchange reaction (Ciccia and Elledge, 
2010; Mehta and Haber, 2014). This activity can be reconstituted in-vitro in the three strand 
exchange reaction where a RAD51 nucleoprotein filament preformed on circular φX174 virion 
ssDNA pairs with and invades ϕX174 linear double stranded DNA (dsDNA) (Baumann et al., 
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1996; Sigurdsson et al., 2001). The DNA strand exchange activity of RAD51 leads to the 
displacement of the complementary linear ssDNA from the dsDNA substrate eventually leading 
to the formation of a nicked circular product through a series of joint molecule intermediates 
(Figure 3.3). The reaction depends on the presence of the ssDNA binding protein RPA, which, 
when added after the RAD51 nucleoprotein filament is formed, stimulates the DNA strand 
exchange by destabilizing remaining secondary structure in the ssDNA and by sequestering the 
displaced DNA strand. The nicked circular product along with the joint molecule intermediates 
are separated on an agarose gel which tracks the progress of the reaction over time.  
 
There are two general regimes under which human RAD51 promotes an efficient DNA 
strand exchange reaction. The reaction can be carried out in the presence of Ca2+ and Mg2+ ions, 
which stabilize the RAD51 nucleoprotein filament by preventing ATP hydrolysis, leading to 
efficient DNA strand exchange (Bugreev and Mazin, 2004). To measure the DNA strand exchange 
activity while permitting ATP hydrolysis, our reaction conditions contained Mg2+ and Ammonium 
Sodium Phosphate (NaNH4PO4) (see methods) (Shim et al., 2006).  RAD51 Y54 phosphomimetic 
mutants showed an enhanced DNA strand exchange activity compared to the wild type protein 
(Figure 3.3). Nicked circular products indicating completion of the reaction, were observed earlier 
in reaction facilitated by RAD51Y54pCMF than in the reaction the wild type protein. We also 
observed an increase in product formed over a time course of 180 minutes from 60% to 80% of 
the input dsDNA (Figure 3.3). The RAD51Y54D and RAD51Y54E mutants were observed to have a 
higher stimulatory effect compared to RAD51Y54pCMF whereas RAD51Y54F behaved identical to 
the wild type protein (Figure 3.4). Two distinct species of the joint molecule intermediates are 
formed during the strand exchange reaction (Tham et al., 2013). The early joint molecule 
intermediates are known to migrate faster in the agarose gel compared to those formed further 
along reaction progression towards the nicked circular product. The stimulation of strand exchange 
activity can be attributed to the efficient conversion of early joint molecule intermediates which 
were observed in much higher amounts for the wild type protein compared to RAD51Y54pCMF 
(Figure3.3), RAD51Y54D or RAD51Y54E (Figure 3.4) mutants. Although mild stimulation of strand 
exchange was observed in the RAD51Y315D or RAD51Y315E mutants, the RAD51Y315pCMF mutant 
showed strand exchange activity identical to the wild type protein (Figure 3.3). Considering the 
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pCMF mutants have the closest structural resemblance to phosphorylated proteins, it is likely that 
the glutamate and aspartate mutations, strongly exaggerate the effects of tyrosine phosphorylation 
in RAD51. 
 
RAD51 phosphomimetic mutants efficiently overcome the kinetic barrier to the 
nucleoprotein filament formation presented by the ssDNA binding protein RPA.  
 The RPA protein plays multiple important roles in HR and in recombination dependent 
DNA repair. While processing DNA double strand breaks, the ssDNA produced by end resection 
machinery is immediately bound by RPA preventing secondary structure formation and further 
stimulates end resection (Symington, 2014). The bound RPA is eventually replaced by RAD51 
nucleoprotein filament in a reaction facilitated by the recombination mediator BRCA2 (Jensen et 
al., 2010; Liu et al., 2010b; Prakash et al., 2015). The in-vitro reconstituted DNA strand exchange 
reaction requires RPA (Baumann et al., 1996; Sung, 1994), which removes secondary structures 
in the ssDNA (Sigurdsson et al., 2001; Sugiyama et al., 1997) and as the reaction progresses, 
sequesters the displaced ssDNA thereby preventing non-productive RAD51 nucleoprotein 
complexes. When added first, however, RPA kinetically impedes the RAD51 nucleation (New et 
al., 1998). Thus, the order of RAD51 and RPA addition while performing the DNA strand 
exchange reaction has a very significant impact on the reaction outcome. As expected, under our 
experimental conditions, the efficiency of nicked circular product formation was significantly 
higher when RAD51-nucleoproten filaments were formed prior to the addition of RPA protein. 
However, while the appearance of the joint molecules and nicked circular products was delayed 
and diminished in the “RPA-first” reactions, it was not completely abolished. Not only did the Y54 
phosphomimetic mutants display higher DNA strand exchange activity in the “RAD51-first” 
reactions, RAD51Y54pCMF displayed no difference in the efficiency between the “RAD51-first” and 
“RPA-first” reactions (Figure 3.5 & 3.6). These experiments suggest that phosphorylated RAD51 
may efficiently displace RPA from the ssDNA in the absence of recombination mediators. As with 
the “RAD51-first” reaction, RAD51Y315pCMF was indistinguishable from the wild type protein 
(Figure 3.5). A slight decrease in the reaction yield was due to the effect of the storage buffer and 
was recapitulated in the wild type protein reaction adjusted to match the buffer. RAD51Y315D and 
RAD51Y315E were more robust DNA strand-exchange proteins than the wild type, RAD51Y315pCMF 
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and RAD51Y315F yet again suggesting that the glutamate and aspartate mutations inaccurately 
represent tyrosine phosphorylation. 
 
Tyrosine phosphorylation limits RAD51 dsDNA binding. 
RAD51 can form nucleoprotein filament on both ssDNA and dsDNA substrates. However, 
only filaments formed on ssDNA substrates are productive in homologous pairing and DNA strand 
exchange (Sung and Robberson, 1995). The recombination mediator BRCA2 is known to promote 
a bias in binding affinity favoring the ssDNA (Jensen et al., 2010; Liu et al., 2010b; Thorslund et 
al., 2010b). We investigated the effect of RAD51 phosphorylation on the RAD51-dsDNA 
interaction by incubating the RAD51 phosphomimetic mutants with ϕX174 dsDNA and analyzing 
the electrophoretic mobility shift. The RAD51Y54pCMF, RAD51Y54D and RAD51Y54E showed a 
significant decrease in the dsDNA binding (Figure 3.7) whereas only a slight decrease was 
observed in RAD51Y315D and RAD51Y315E. As expected, the Y/F substitution had no effect on the 
RAD51-dsDNA interaction. The decrease in dsDNA binding in all RAD51 mutants directly 
correlated with the stimulation of the DNA strand exchange activity. The only deviation from this 
trend was RAD51Y315pCMF, which upon incubation with the supercoiled ϕX174 dsDNA formed 
large aggregates that failed to enter the gel. Similar experiments were performed on shorter dsDNA 
substrates with results consistent with those from the ϕX174 dsDNA substrate (data not shown).  
 
The altered ssDNA binding behavior of phosphomimetic mutants 
To elucidate the regulation of RAD51 nucleoprotein filament formation on ssDNA, we 
investigated the RAD51-ssDNA interaction using Forster Resonance Energy Transfer (FRET) 
based assays (see methods). These experiments monitored binding of RAD51 to a Poly dT60 
substrate which was labelled internally with Cy3 (FRET donor) and Cy5 (FRET acceptor) 
fluorescent dyes separated by 25 nucleotides. Free ssDNA yields a high FRET value due to the 
proximity of the donor and acceptor dyes. Addition of RAD51 into the reaction mixture and 
ensuing nucleoprotein filament formation extends the ssDNA, which can be measured as a 
decrease in FRET as the two fluorophores move away from each other (Subramanyam et al., 2013). 
RAD51 protein binds and extends ssDNA1.5 fold beyond its contour length with each RAD51 
monomer occluding approximately three nucleotides as evident by the FRET of approximately 
0.55, compared to 0.19 expected for the fully extended B-form ssDNA (Figure 3.8). ATP bound 
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RAD51 forms stable nucleoprotein filaments (Namsaraev and Berg, 1998) while hydrolysis of 
ATP to ADP leads to the protein turnover. Using an NADH coupled ATPase assay (see methods), 
we measured ATP hydrolysis activity for all phosphomimetic mutants. All mutants could 
hydrolyze ATP similar to the wild type protein. (Figure 3.9D).  
The characteristic ssDNA binding and extension was observed in buffers which permitted 
ATP hydrolysis (Mg2+/ NaNH4PO4) as well as under conditions which inhibited ATP hydrolysis 
(Ca2+/Mg2+/KCl) (Figure 3.8). Under both sets of experimental conditions we observed a 
stoichiometric binding of the RAD51 protein to 600 nM (nucleotides) ssDNA. Under these 
conditions, RAD51Y54pCMF binding to and extension of the ssDNA was indistinguishable from the 
wild type protein, while RAD51Y54D and RAD51Y54E showed weaker binding to the ssDNA 
substrate (Figure 3.9A & B). Under conditions permitting ATP hydrolysis, binding of the 
RAD51Y54pCMF to the ssDNA was no longer stoichiometric as higher concentrations of 
RAD51Y54pCMF were required to saturate the ssDNA substrate compared to wild type. This binding 
deficiency was even more pronounced in the RAD51Y54D were RAD51Y54E proteins, which 
respectively required approximately 6- and 160-fold more protein to saturate the ssDNA substrate 
(Figure 3.8). No difference between the wild type RAD51 and RAD51Y54F was observed. 
RAD51Y315E and RAD51Y315pCMF mutants displayed ssDNA binding only slightly weaker than the 
wild type under ATP hydrolysis conditions while formed stable nucleoprotein filaments similar to 
wild type when hydrolysis was inhibited (Figure 3.9C & D). All other RAD51 Y315 mutants 
showed binding characteristics similar to the wild type protein under both, permissive and 
inhibitory conditions for ATP hydrolysis. The inverse correlation between the ssDNA binding and 
the capacity to carry out the DNA strand exchange activity was somewhat unexpected. This is 
especially true for the RAD51Y54D which in contrast to other mutants does not show ssDNA 
nucleoprotein filament formation even at the tens of µM concentrations exceeding those of the 
DNA strand exchange reactions. This apparent discrepancy can be explained from the previous 
studies (Carreira et al., 2009) which showed that RAD51 forms less stable complexes with short 
oligonucleotides: while RAD51 dissociates from the shorter oligonucleotides normally, 
reassembly of the nucleoprotein filament is blocked under the steady-state conditions. RAD51 
forms stable nucleoprotein filaments on longer ssDNA much more efficiently. The same is likely 
applies to the phosphomimetic mutants. 
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Equilibrium single-molecule measurements quantify RAD51-ssDNA binding  
 To further understand the effect of the RAD51 Y54 phosphorylation, we employed single-
molecule Total Internal Reflection Fluorescence Microscopy (smTIRFM). A FRET-based analysis 
(Joo et al., 2006) was used to follow binding of RAD51 to the individual surface-tethered partial 
DNA duplex molecules, where the Cy3 and Cy5 dyes were separated by 21 nucleotides and the 
overall ssDNA region was 60 nucleotides (Figure 3.8 & Figure 3.10). Similar to the bulk ssDNA-
binding experiments described above, the Cy3 dye is excited with the green (532 nm) laser and 
the Cy5 dye is excited via FRET. Measurements collected for 3839 RAD51-free DNA molecules 
from fifteen second movies yielded a normally distributed FRET peak with an average FRET value 
of 0.5. A second smaller peak distributed around 0 FRET value represents the fraction of molecules 
that underwent acceptor photo-bleaching. Upon binding by RAD51, the donor and acceptor dyes 
move apart as the ssDNA molecule is stretched. This manifests in the change from high to low 
FRET. The DNA molecules fully extended by the bound RAD51 yielded a FRET distribution with 
an average FRET of approximately 0.1. Using this system, we compared the binding properties of 
the wild type RAD51 with RAD51Y54pCMF. The concentration-dependence of these reactions 
recapitulates the data observed in bulk, except binding of the RAD51 protein here is not 
stoichiometric and therefore can be directly compared to that of RAD51Y54pCMF. A clear difference 
was observed wherein, 250nM of RAD51 was required to fully extend the ssDNA substrates 
whereas 2.5μM of the Y54pCMF mutant was required to achieve similar results (Figure 3.8). This 
is approximately a 10-fold increase in protein required to form stable nucleoprotein filaments. 
Notably, these measurements predict that both proteins will bind and extend the ssDNA at 
concentrations used in the DNA strand exchange reaction.  
 
RAD51 nucleates ssDNA as a dimer  
 To visualize the nucleation of the RAD51 filament on ssDNA in real time, we carried out 
smTIRFM flow experiments. In these experiments RAD51 was introduced into a reaction chamber 
containing tethered ssDNA molecules as described earlier, but 10 seconds into the recording. 
Movies were recorded for three minutes at a time resolution of 100 milliseconds. The fluorescence 
trajectories (time-based changes in Cy3 and Cy5 fluorescence originating from distinct spots on 
the slide) were collected. The trajectories that contained binding events were then corrected for 
donor leakage and trimmed to contain all events prior to donor or acceptor photo-bleaching (Figure 
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3.11A & B show representative trajectories). Only events containing anti-correlated trajectories 
for donor and acceptor intensities were selected for further FRET analysis. Selected trajectories 
were then analyzed collectively using ebFRET (van de Meent et al., 2014) to determine the number 
of distinct states in the trajectories. This program uses an Empirical Bayesian method to generate 
Hidden Markov Models (HMM) to analyze complex FRET trajectories. In our experiments, on 
addition of 250nM of the wild type RAD51, filament formation was observed to proceed in a step 
wise manner. The trajectories were fit to models for two to eight distinct FRET states. The model 
that best fitted the trajectories was determined by calculating the statistical mean lower bound per 
series output from the ebFRET program. The model that showed the best fit was then visually 
compared with the raw data (Figure 3.11A & B). All data points in the fit dataset were also plotted 
as frequency histograms which indicate the value of the individual FRET states as a Gaussian 
distribution. Models that under-fit or over-fit the dataset can be distinguished using this method 
and eliminated.  Four distinct states were observed between FRET values of 0.5 and 0.1 (Figure 
3.11C & D) indicating three steps. Since the donor and acceptor dyes are separated by 21 bases 
and each RAD51 monomer binds ssDNA as a triplet (Lee et al., 2015), we conclude that the basic 
unit for binding and extension of RAD51 nucleoprotein filaments is a dimer. At similar 
concentrations, no binding events were observed with RAD51Y54pCMF. However, at 2.5μM 
RAD51Y54pCMF, multiple trajectories were observed with assembly and dissociation events for both 
the wild type protein and for the RAD51Y54pCMF mutant. Both proteins were found to bind and 
extend the nucleating nucleoprotein filament as a dimer. To determine the dynamics of the nucleus 
assembly, the transitions between multiple FRET states were plotted as transition density plots 
(TDP) (McKinney et al., 2006) (Figure 3.12). This plot represents the FRET state of a molecule 
prior to and after the transition on the horizontal and vertical axes respectively. Interestingly, at a 
lower concentration of 250nM, RAD51 nucleation includes transitions in the forward 
(S1→S2→S3→S4) and the reverse direction (S4→S3→S2→S1) with similar frequencies 
indicating a very dynamic process whereby RAD51 dimers rapidly bind and dissociate at each step 
of the filament formation. At higher concentrations of 2.5μM, a bias was observed towards 
transitions between the final two states, i.e. S3→S4 transitions are the most prevalent with lower 
occupancy in the density of S4→S3 transitions. This shows that the nucleoprotein filament 
nucleation proceeds in the forward direction. Analysis of the RAD51Y54pCMF showed no binding 
events at 250nM protein concentration. However, the RAD51Y54pCMF filament nucleation was 
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highly efficient compared to wild type RAD51 at higher concentrations of RAD51Y54pCMF, i.e. 
2.5μM. Experiments were also performed at an intermediate concentration of 750nM of protein 
where RAD51Y54pCMF was able to form filaments with a stronger forward directionality compared 
to the wild type protein.  
It is important to note that the studies reported above are pre-equilibrium measurements that 
follow the initial steps of the filament nucleation process. When the reactions were allowed to 
reach an equilibrium (i.e. 5 – 10 min after the addition of RAD51 or RAD51Y54pCMF to the surface-
tethered DNA), we observed a stable low FRET signal indicative of the fully-formed nucleoprotein 
filaments. 
To determine whether the differences between the nucleation mechanisms of the wild type 
RAD51 and RAD51Y54pCMF are due to differences in their respective capacity to form dimers 
required for the filament nucleation we analyzed the oligomeric state of the phosphomimetic 
proteins by native PAGE (Figure 3.13). This analysis was carried out at 7.5 µM of each protein, 
which is the concentration used in our DNA strand exchange reactions. Prior to loading on the gel, 
the proteins were incubated in the strand exchange buffer. While all assayed proteins showed a 
tendency to form large oligomeric complexes, slightly lower molecular weight and more discrete 
bands were observed for the RAD51Y54pCMF, RAD51Y54D and RAD51Y54E mutants. 
  
 
Discussion 
 
Here, we addressed the biochemical consequences of RAD51 phosphorylation by c-Abl/BCR-
ABL using phosphomimetic mutants that accurately mimic the effect of tyrosine phosphorylation 
(Honda et al., 2009; Xie et al., 2007). First, we showed that RAD51Y54pCMF protein has an enhanced 
DNA strand exchange activity on the plasmid-length substrates (Figure 3.3A). Our findings 
contrast previous biochemical studies where phosphorylation of Y54 on RAD51 was thought to 
inhibit the DNA strand exchange (Yuan et al., 1998), but is in an excellent agreement with cellular 
studies where RAD51 nucleoprotein formation was enhanced after c-Abl phosphorylation (Yuan 
et al., 2003). These earlier biochemical studies were performed using sceRad51 phosphorylated in 
vitro by human c-Abl. While the tyrosine residue analogous to Y54 is conserved in sceRad51, 
yeast cells lack tyrosine phosphorylation (Lim and Pawson, 2010) resulting in different 
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mechanisms of regulation for the yeast and human proteins. This makes our studies the first to 
mechanistically address and to parse out the effects of the two tyrosine phosphorylation events on 
RAD51 activities. We observed that the Y54 phosphorylation enhances the recombinase activity 
of RAD51 in at least three important ways. Firstly, RAD51Y54pCMF appeared to efficiently promote 
nicked circular DNA formation, the DNA strand exchange product, while the joint molecule 
intermediates accumulated to a much greater extent in the reactions utilizing the unmodified 
RAD51 protein (Figure 3.3). Human RAD51 readily forms the DNA joint-molecules, but, in 
contrast to its bacterial functional homolog RecA, is inefficient at their branch migration 
(Baumann et al., 1996). Y54 phosphorylation appears to alleviate this deficiency allowing for a 
rapid clearing of the intermediates and formation of the DNA strand exchange products. Second 
and most unexpectedly, RAD51Y54pCMF was able to enhance the so-called “RPA-first” reaction 
allowing it to reach the extent of the “RAD51-first” reaction (Figure 3.5A). The ssDNA binding 
protein RPA plays both inhibitory and stimulatory roles at different HR steps. RPA stimulates the 
DNA strand exchange by removing regions of the secondary structure in the ssDNA, which allows 
RAD51 to form a contiguous nucleoprotein filament (Sugiyama et al., 1997), and also sequesters 
the displaced DNA strand thereby assisting in progression of the reaction from the joint molecule 
intermediates to the nicked circular products by competing with RAD51 for free ssDNA 
(Sigurdsson et al., 2001). If added to the ssDNA first (“RPA-first” reaction), RPA delays the 
RAD51 nucleoprotein filament formation by kinetically inhibiting the nucleation step (New et al., 
1998). This inhibition is overcome by the recombination mediator activity of BRCA2 (Jensen et 
al., 2010; Liu et al., 2010b). Robust DNA strand exchange reaction promoted by RAD51Y54pCMF 
suggests that RAD51 protein phosphorylated by the c-Abl kinase may nucleate on the RPA-coated 
ssDNA and form contiguous active nucleoprotein filaments even in the absence of the 
recombination mediator. However, a scenario where the DNA damage response leads to a 
coordinated activation of several simultaneous pathways that ensure faithful and efficient 
recombination mediated DNA repair is more likely. BRCA2 has been shown to diffuse in the 
nucleus together with RAD51 delivering it to the sites of DNA damage (Reuter et al., 2014) with 
each BRCA2 binding 4-5 RAD51 monomers and promoting the filament nucleation (Jensen et al., 
2010; Shahid et al., 2014). Phosphorylation of RAD51 may then ensure the filament growth on the 
RPA-coated ssDNA, as the RAD51 focus formation is reduced in c-Abl-/- cells (Yuan et al., 2003). 
Finally, the selectivity of the RAD51Y54pCMF towards binding the ssDNA over dsDNA (Figures 3.7 
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and 3.8) is another means of enhancing the RAD51-mediated DNA strand exchange reaction by 
favoring the formation of active nucleoprotein filament, and is also akin to the function of the 
recombination mediator (Jensen et al., 2010; Sung and Robberson, 1995).  
In contrast to RAD51Y54pCMF, RAD51Y315pCMF displayed the biochemical activities essentially 
similar to those of the unmodified protein. These data are consistent with a sequential 
phosphorylation of RAD51 proposed earlier (Colicelli, 2010; Popova et al., 2011). According this 
this model, c-Abl phosphorylates RAD51 on Y315 by binding the consensus PXXP motif through 
its SH3 domain. Phosphorylation of Y315 residue then forms a pYXXP motif which is a consensus 
binding motif for the SH2 domain of c-Abl. This in turn leads to phosphorylation of the Y54 
residue which upregulates DNA repair activity through stimulation of the RAD51-mediated DNA 
strand exchange.  
The ostensible discrepancy between the enhanced DNA strand exchange activity of 
RAD51Y54pCMF and its reduced capacity to bind ssDNA was unexpected. A ten-fold difference in 
the concentration of the unmodified RAD51 and RAD51Y54pCMF required to bind and extend the 
ssDNA under conditions identical to those used in the DNA strand exchange reactions (Figure 
3.8B) may be explained as reduced affinity for ssDNA, change in the binding cooperativity, or in 
the altered RAD51 oligomerization. RAD51 nucleoprotein filaments were shown to grow from 
heterogeneous nuclei ranging size from dimers and even monomers to large oligomers (Candelli 
et al., 2014). Using single-molecule TIRFM we were able to follow the formation kinetics of these 
nuclei at a single monomer resolution. We observed no RAD51 monomers binding to ssDNA, but 
showed that both RAD51 and RAD51Y54pCMF interact with ssDNA as a dimer. The nucleus then 
grows by dynamic addition and dissociation of the RAD51 dimers. At intermediate and high 
protein concentrations, growth of the RAD51Y54pCMF nucleus is more directional than that of the 
unmodified RAD51, which manifests in fewer transitions in the reverse direction (Figure 3.12B). 
The lack of the DNA binding at 250 nM RAD51Y54pCMF may be due to the decreased 
oligomerization of the phosphomimetic protein brought about by a possibly slightly distorted 
monomer-monomer interface. Y54 is located in the N-terminal domain of RAD51 near the 
monomer-monomer interface. In the unmodified protein, it participates in the stacking interaction 
with F195 of the adjacent monomer (Subramanyam et al., 2013). Introduction of the negative 
charge upon Y45 phosphorylation or due to the presence of phosphomimetic residue may affect 
this interface so that the RAD51 oligomerization is delayed until higher protein concentrations. 
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Although RAD51 nucleates the nucleoprotein filaments at much lower protein concentrations, 
these complexes are dynamic, unstable, and are likely non-productive with respect to formation of 
the recombination proficient nucleoprotein filaments. On the other hand, RAD51Y54pCMF while 
unable to form these early unstable filaments at lower protein concentrations forms more stable, 
recombination proficient nucleoprotein filaments at higher protein concentrations. The same 
properties that allow RAD51Y54pCMF dimers to directionally and rapidly assemble into the 
contiguous nuclei, are also likely underlie its ability to displace RPA and to efficiently carry out 
the “RPA-first” DNA strand exchange reactions.  
 
Materials and Methods 
 
Protein Expression & Purification 
To achieve a robust expression system compatible with both, the expression of the soluble 
RAD51 protein and efficient pCMF incorporation, the RAD51 open reading frame was codon 
optimized for E. coli expression and cloned into a pCOLADuet (Novagen) expression vector 
which also encoded for the E. coli GroE Operon. The resulting plasmid is referred herein as pCH1-
RAD51. Protein incorporating pCMF was expressed in E. coli Acella™ Cells (F- ompT hsdSB(rB- 
mB
-) gal dcm (DE3) ∆endA ∆recA). These cells were transformed with the pCH1 vector encoding 
E. coli codon optimized RAD51 Y54TAG and Y54315TAG sequences, along with the pSUPT-
UaaRS vector encoding the amber tRNA and pCMF-RS expressed under proK and araBAD 
promoters respectively. E. coli Acella™/pCH1-RAD51 cells were taken from a glycerol stock and 
inoculated in 10 ml of LB Broth containing 40µg/ml Kanamycin and incubated at 37C overnight. 
8ml of the overnight culture was used to seed a 1L LB culture containing 40µg/ml Kanamycin. 
The culture was grown at 37C until an OD600 of ~0.6 was reached. RAD51 expression was then 
induced for 4 hours at 37C with 0.1 mM IPTG. The cells were pelleted and stored at -80C for 
protein purification.  RAD51 protein was then purified using the protocol described previously 
(Subramanyam et al., 2013). Briefly, cells from the RAD51 expression were thawed on ice for two 
hours and resuspended in lysis buffer containing protease inhibitors and lysozyme. The cells were 
then sonicated and the soluble fraction was dialyzed against spermidine acetate buffer. Spermidine 
precipitates RAD51 which is selectively resuspended in buffers containing increasing amounts of 
sodium chloride. The fractions containing RAD51 are then purified through a Blue Agarose 
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column followed by a Heparin column. Finally, the protein collected from this step is concentrated 
using a MonoQ anion exchange column.  RAD51 pCMF mutants were expressed similarly to the 
wild type protein except that, E. coli Acella™/pCH1-RAD51/pSUPT-UaaRS starter cultures were 
seeded to 2L culture volumes and grown in the presence of 34μg/ml chloramphenicol and 1% 
arabinose in addition to 40µg/ml Kanamycin. These cultures were then induced as described above 
with IPTG along with 300μg/ml of p-carboxymethyl-L-phenylalanine (custom synthesized by 
AsisChem). The wild type protein concentration was determined using molar extinction coefficient 
of 14900 M-1cm-1 at A280. The concentrations for all mutants were measured using molar extinction 
coefficient of 13410 M-1cm-1 at A280. Human RPA was purified as described earlier (Henricksen 
et al., 1994). 
 
DNA Strand Exchange Assay 
RAD51 DNA Strand Exchange Assay was performed similarly as described earlier 
(Sigurdsson et al., 2001). The assay was performed using the φX174 virion ssDNA and the φX174 
RFI dsDNA as substrates for the reaction. The φX174 RFI dsDNA was linearized using ApaLI to 
generate 4 base pair, 5’ overhangs, and purified using phenol-chloroform-isoamyl alcohol 
extraction. The “RAD51-first” DNA strand exchange reactions were initiated by incubating 7.5µM 
RAD51 with 30µM (Nucleotide) φX174 ssDNA and 2.5mM ATP in the Reaction Buffer (20mM 
HEPES-NaOH pH 7.5, 10% Glycerol, 1mM MgCl2 and 1mM DTT) for 5 minutes at 37°C. To 
this, 150mM of NaNH4PO4 was added along with 2µM RPA unless indicated otherwise, and 
incubated for another 5 minutes. This was followed by addition of 15µM (base pair) of ApaLI-
digested Linear φX174 dsDNA and further incubation at 37°C over for 30, 60, 90 or 120 min. All 
concentrations were determined for a 90µl Reaction volume. The samples were then deproteinized 
by addition of 0.8% SDS and Proteinase K (800µg/ml) followed by incubation at 37°C for 30 
minutes and resolved on a 0.8% Agarose gel (UltraPure Agarose) at 3.5V/cm (60V) at 25°C for 
16 hours. The gel was then stained for 10 minutes using SYBR Gold and then destained for 20 
minutes in MilliQ H2O. In the “RPA-first” reactions the order of addition of RAD51 and RPA was 
reversed. The appearance of the nicked circular products were quantitated using ImageJ software 
normalized to the amount of initial linear dsDNA substrate. The intensities obtained for the 
mutants were then statistically compared to the wild type strand exchange reaction using two way 
ANOVA and verified for significance.  All data were plot using GraphPad Prism 6.  
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ATPase Assay 
A coupled NADH assay was performed as described earlier (Kreuzer and Jongeneel, 1983). 
A reaction mixture was assembled containing 20mM HEPES-NaOH pH7.5, 5mM MgCl2, 150mM 
NaNH4PO4, 1mM DTT, 0.2mg/ml NADH, 7.5mM Phosphoenol Pyruvate, 2.5mM ATP, 20U of 
Lactate Dehydrogenase and Pyruvate Kinase and 7.5μM RAD51. The reaction was incubated at 
37°C and A340 measured using an Agilent 8453 UV-Vis Spectrophotometer. 80µM nucleotides of 
poly dT100 was added to start the DNA dependent ATP hydrolysis. The slope of the decrease of 
NADH absorbance at 340nm was used to calculate the rate of ATP hydrolysis using the following 
conversion: rate of A340 decrease (s
-1) × 9880 = rate of ATP hydrolysis (µM/min). Data were plotted 
using GraphPad Prism 6. 
 
RAD51 DNA Binding & Extension Assay 
The FRET based DNA binding assay for RAD51 was performed as described in 
(Subramanyam et al., 2013). Six hundred nM (nucleotides) of dT60 oligo labeled with the Cy3 and 
Cy5 dyes separated by 25 nt was titrated with RAD51 protein in FRET Reaction Buffer (20mM 
HEPES pH 7.5, 5mM CaCl2, 5mM MgCl2,  150mM KCl, 1mM ATP, 1mM DTT or 20mM HEPES 
pH 7.5, 150mM NaNH4PO4, 2mM MgCl2, 1mM ATP, 1mM DTT) at 37˚C.  Cy3 and Cy5 
fluorescence was recorded using Cary Eclipse Fluorimeter. FRET was calculated as a fraction of 
acceptor intensity relative to the total donor and acceptor intensity adjusted by correction factors 
–  
              4.2*Icy5             . 
(4.2*Icy5) + (1.7*Icy3) 
 
 
FRET value was plotted against the concentration to observe RAD51 DNA Binding and Extension 
characteristics. Data were plotted using GraphPad Prism 6. 
 
 
 
68 
 
dsDNA Binding Assay 
RAD51 dsDNA binding assay was performed largely as described in (Takizawa et al., 
2004). The reaction was initiated by incubating 2.5µM, 5µM and 7.5µM RAD51 with 15µM (base 
pair) φX174 dsDNA in 4X Reaction Buffer (80mM HEPES-NaOH pH7.5, 40% Glycerol, 4mM 
MgCl2, 4mM Dithiothreitol and 0.4mg/ml BSA) and 2.5mM ATP and 150mM of indicated salt for 
20 minutes at 37°C. The samples were then mixed with 6X DNA Loading Dye and resolved on a 
0.8% Agarose gel at 3.5V/cm (50V) at 25°C for ~3 hours. The gel was then stained for 10 minutes 
using SYBR Gold and then de-stained for 10 minutes in MilliQ H2O. 
 
 
Acquisition of Single Molecule Data 
A diode-pumped solid state (DPSS) 532nm green laser was used to excite Cy3 molecules 
in an evanescent field produced in a reaction chamber. Scattered light was removed using Cy3/Cy5 
dual band-pass filter (Semrock, FF01-577/690) in the emission optical pathway Images were 
chromatically separated into Cy3 image and Cy5 image using 630-nm dichroic mirror inside the 
dual view system (DV2; Photometrics). The data acquisition was carried out through an Andor 
IXON CCD camera, using software written in Visual C++. The movies obtained with the CCD 
were analyzed first using IDL and the intensities of the fluorophores and the time traces were 
visualized using customized MATLAB programs. FRET was calculated using the equation (Ha, 
2001) –  
 
𝐸 =
1
(1 + 𝛾
𝐼𝐷
𝐼𝐴
)
−1
 
 
 
The where 𝐼𝐷 and 𝐼𝐴 are the sensitized emission intensity of the donor and acceptor, respectively. 
The measured raw intensities of the donor and acceptor channels were then corrected by measuring 
the leakage intensities from the donor channel β to the acceptor channel. The donor leakage was 
subtracted from the acceptor channel intensities and added it back to the donor intensity. For our 
optical setup, the donor leakage correction was measured to be 7%. Applying this correction, we 
get the equation for FRET given below –  
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𝐸 =
(𝐼𝐴
∗ − 𝛽)
(𝐼𝐴
∗ − 𝛽) + 𝛾(𝐼𝐷
∗ + 𝛽) 
 
 
Where, 𝐼𝐴
∗ and 𝐼𝐷
∗   are the background corrected acceptor and donor intensity. 𝛾 = 1, is calculated 
as the ratio of change in the acceptor intensity, ΔIA to change in the donor intensity, ΔID upon 
acceptor photobleaching (γ = ΔIA / ΔID) (Joo and Ha, 2012b; Roy et al., 2008). 
 
Single-Molecule RAD51 DNA Binding Assay (TIRFM) 
An oligo made of 18 random bases and was labelled with a 5’ Cy5 dye and a 3’ biotin tag. 
This oligo was annealed to a 78 base oligo containing the complementary 18 bases to the 
biotinylated oligo followed by a T60 sequence and an internal Cy3 dye spaced 21 bases apart from 
the Cy5 dye on the tethered oligo. This arrangement ensures that all oligos tethered to the slide 
have a complete FRET pair. PEGylated slides and sample chamber were prepared as described 
earlier (Joo and Ha, 2012a). 100µl of 0.2mg/ml Neutravidin was passed through the reaction 
chamber and incubated for 3 minutes. The chamber was washed with 300µl T50 buffer (Tris pH 
8.0, 50mM NaCl). Fifty pM Biotinylated DNA substrate was then added to the Imaging Buffer 
(Trolox, 20mM HEPES pH 7.5, 2mM MgCl2, 0.8% Glucose, 150mM NaNH4PO4, 1mM ATP, 
1mM DTT, 0.1mg/ml BSA, 0.04 mg/ml Catalase and 1 mg/ml Glucose Oxidase) and flowed into 
the chamber. The indicated concentrations of RAD51 were then added into the Imaging Buffer 
and flowed into the imaging chamber. Forty movies of 15 second duration (100 ms time resolution, 
400 background value and 1600 data scalar) were recorded using gain of 230 at 45.6 mW green 
laser intensity. Data were analyzed using customized programs for IDL & MATLAB. The DNA 
substrates used for the experiment are 5Cy5-Bot18-3Bio (GCCTCGCTGCCGTCGCCA) and 
Top18-(T21)Cy3(T39) (TGGCGACGGCAGCGAGGCTTTTTTTTTTTTTTTTTTTTT/iCy3/TT 
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT).  
For experiments performed under flow, similar conditions were used to set up the experiment 
except 75 pM of the DNA substrate was used instead of 50 pM to account for uniform 
concentration of molecules in a larger flow chamber. Once the DNA substrate was bound to the 
PEGylated slide, the imaging chamber was washed with the RAD51 Imaging Buffer. Using the 
same values for laser power and gain, three minute movies were recorded at the same time 
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resolution with the indicated concentration of RAD51 being injected into the imaging chamber at 
~10 seconds into the movie recording.  
 
Analysis of Single Molecule binding Data 
To generate FRET state histograms, five frames from each movie were used to calculate 
the FRET values for each frame for each molecule in the movie and plotted as a FRET histogram 
after the data were normalized in MATLAB. Each histogram was fit to a Gaussian distribution or 
to a sum of Gaussians using GraphPad Prizm. The area under the histogram defined the percentage 
of molecules in each FRET state.  
The time dependent trajectories obtained from flow experiments were analyzed using Hidden 
Markov Modeling. Empirical Bayesian methods were used to determine transitions indicating 
RAD51 filament formation. The leakage corrected trajectories were trimmed to include all data 
points until donor/acceptor photo-bleaching events. ebFRET analysis suite (van de Meent et al., 
2014) was used to statistically determine the FRET states observed in the course of the RAD51 
nucleoprotein filament formation. Mean lower bound was used to determine the evidence for the 
model that best described the number of states for each series. This was confirmed by visually 
comparing the idealized trajectories from the model with the raw data to confirm the fit. 
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Figures
 
Figure 3.1. Incorporation of pCMF into RAD51 
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Figure 3.1. Incorporation of pCMF into RAD51 (A) Homology model of two adjacent RAD51 
monomers. RAD51 DNA binding loops L1 & L2 are shown in orange and green respectively. 
Residues Y54, Y315, and F195 are shown in ball and stick rendering. (B) The structures of 
tyrosine, phosphorylated tyrosine and the non-natural amino acid pCMF (p-Carboxymethyl-L-
phenylalnine). (C) Schematic showing expression system for the pCMF incorporation using the 
amber suppressor system. RAD51 expression in the absence of pCMF leads to translation of a 
truncated product, whereas full length protein is produced on addition of the pCMF amino acid 
into the expression media. (D) Western blot showing expression of full length RAD51Y54pCMF and 
RAD51Y315pCMF proteins using mouse anti-RAD51 (3C10) antibody. Truncated products are 
observed in the absence of pCMF (Y54 truncations are too small to be verified by standard gel-
electrophoresis). (E) SDS-PAGE gel showing purified RAD51, RAD51Y54pCMF and 
RAD51Y315pCMF. The RAD51Y315pCMF have a very small amount of truncated product (<10%) that 
could not be separated using our purification scheme (Figure S1B). 
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Figure 3.2. Incorporation of non-natural amino acid into RAD51 protein. 
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Figure 3.2. Incorporation of non-natural amino acid into RAD51 protein. (A) Expression 
system established for incorporation of the pCMF amino acid consists of E. coli Acella™ cells 
transformed with two plasmids. The first plasmid, pCH1-RAD51opt contains anRAD51 ORF 
optimized for E. coli expression as well as the GroE operon from E. coli. The second plasmid 
contains components for the amber suppressor system. (B) Purification scheme for obtaining 
homogeneous RAD51 protein. (C) SDS-PAGE gel showing purified RAD51 and phosphomimetic 
mutants. (D) Data from MALDITOF-MS experiments confirming incorporation of pCMF amino 
acid at the Y54 (top) and Y315 (bottom) residues respectively.   
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Figure 3.3. Y54 phosphorylation stimulates DNA strand exchange activity of RAD51 
76 
 
Figure 3.3. Y54 phosphorylation stimulates DNA strand exchange activity of RAD51 (A) 
Schematic showing the biochemically reconstituted DNA strand exchange reaction. Circular 
ϕX174 ssDNA is incubated with RAD51 in reaction conditions permitting ATP hydrolysis (see 
methods) followed by addition of RPA which helps remove secondary structures in the ssDNA 
allowing stable nucleoprotein filament formation. The RAD51 nucleoprotein then invades ϕX174 
linear dsDNA to form nicked circular dsDNA products through several joint-molecule 
intermediates showing various stages of branch migration. (B) Strand exchange reactions carried 
out by RAD51 (left), RAD51Y54pCMF (middle) and RAD51Y315pCMF (right). For each protein, the 
respective panel shows reactions stopped at 0, 30, 60, 120 and 180 min. All substrates, joint-
molecules and nicked circular products are observed on a 0.8% TAE agarose gel stained with 
SYBR Gold. (C) Quantitative analysis of formed nicked circular products. The RAD51Y54pCMF 
mutant (red) is able to convert ~80% of linear dsDNA substrate into nicked circular products 
compared to ~58% products formed for RAD51 wild type (grey) and RAD51Y315pCMF mutant 
(orange) over a 180 minute time course. All reactions were performed in triplicate with data 
represented as mean ± SEM. The results for both mutants were compared to the wild type protein 
using two way ANOVA to verify significance of results. 
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Figure 3.4. Strand exchange reactions with RAD51 Y54 & Y315 mutants 
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Figure 3.4. Strand exchange reactions with RAD51 Y54 & Y315 mutants (A) Schematic 
showing the in vitro reconstituted “RAD51-first” DNA strand exchange reaction (Figure 2). (B) 
Strand exchange reactions comparing RAD51 wild type to RAD51Y54D, RAD51Y54E and 
RAD51Y54F mutants respectively. (C) Strand exchange reactions comparing RAD51 wild type to 
RAD51Y315D, RAD51Y315E and RAD51Y315F mutants respectively. 
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Figure 3.5. RAD51Y54pCMF performs efficient “RPA-first” DNA strand exchange 
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Figure 3.5. RAD51Y54pCMF performs efficient “RPA-first” DNA strand exchange (A) 
Schematic explaining the “RPA-first” reactions. Circular ϕX174 ssDNA is incubated with RPA 
protein. This is followed by RAD51 protein which displaces the bound RPA to form nucleoprotein 
filaments which can then invade ϕX174 linear dsDNA to form nicked circular products through a 
series of joint-molecule intermediates. (B) “RPA-first” DNA strand exchange reactions carried out 
by RAD51 (left), RAD51Y54pCMF (middle) and RAD51Y315pCMF (right). For each protein, the 
respective panel shows reactions stopped at 0, 30, 60, 120 and 180 min. (C) “RPA-first” DNA 
strand exchange reactions carried out by RAD51 (left) and RAD51Y315pCMF (right). (D&E)  
Quantitation of product formed in the DNA strand exchange reactions. The RAD51Y54pCMF mutant 
(blue) converts ~80% of linear dsDNA substrate into nicked circular products in the presence of 
RPA compared to ~20% products formed for RAD51 wild type (black) while RAD51Y315pCMF 
mutant (cyan) is similar to wild type protein in both “RAD51-first” and “RPA-first” reactions. All 
reactions were performed in triplicate with data represented as mean ± SEM. The results for both 
mutants were compared to the wild type protein using two way ANOVA to verify significance of 
results. 
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Figure 3.6. “RPA-First” Strand exchange reactions with RAD51 Y54 & Y315 mutants 
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Figure 3.6. “RPA-First” Strand exchange reactions with RAD51 Y54 & Y315 mutants (A) 
Schematic showing the in vitro reconstituted “RPA-first” DNA strand exchange reaction (Figure 
3). (B) Strand exchange reactions comparing RAD51 wild type to RAD51Y54D, RAD51Y54E and 
RAD51Y54F mutants respectively. (C) Strand exchange reactions comparing RAD51 wild type to 
RAD51Y315D, RAD51Y315E and RAD51Y315F mutants respectively. 
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Figure 3.7. RAD51 phosphorylation limits dsDNA binding. (A) Electrophoretic mobility shift assay (EMSA) RAD51 Y54 
mutants binding supercoiled ϕX174 dsDNA. 25μM (base-pair) dsDNA was incubated with increasing concentrations of 2.5μM, 
5.0μM or 7.5μM RAD51 and loaded on a 0.8% TAE agarose gel and stained with SYBR gold. RAD51Y54pCMF, RAD51Y54D, 
RAD51Y54E showed decrease in dsDNA binding compared to wild type protein and RAD51Y54F. (B) In a similar assay 
RAD51Y315pCMF formed aggregates that failed to enter into the gel whereas RAD51Y315D, RAD51Y315E mutants showed slightly 
reduced dsDNA binding compared to RAD51 and RAD51Y315F. 
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Figure 3.8. Effects of Y54 phosphorylation on ssDNA binding activity 
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Figure 3.8. Effects of Y54 phosphorylation on ssDNA binding activity (A) RAD51 binding to 
ssDNA was observed by following the extension of the 60-mer oligonucleotide poly(dT)-60 
containing Cy3 (FRET donor) and Cy5 (FRET acceptor) fluorophores separated by 25 nucleotides. 
Binding of RAD51 to 600nM (Nucleotide) ssDNA moves the two dyes apart which can be seen 
as a change from high FRET (0.55) to low FRET (0.19). Under conditions preventing ATP 
hydrolysis (Ca2+) the RAD51Y54pCMF binds and extends the ssDNA substrate similar to wild type 
RAD51 with a 1:3 RAD51:ssDNA ratio, whereas under reactions conditions permitting ATP 
hydrolysis (Mg2+) RAD51Y54pCMF binding in non-stoichiometric. (B) Analysis of the equilibrium 
ssDNA binding using single-molecule TIRFM. FRET histograms indicating binding of RAD51 to 
immobilized ssDNA substrate (see methods, Figure S5). Unbound ssDNA yeilds a histogram 
centered on FRET value of (~0.5), while fully extended RAD51 nucleoprtoein filament yields a 
histogram centered on ~0.1 FRET value. Grey and blue histograms represent FRET values in the 
absence and presence of RAD51 respectively. Concentrations of RAD51 or RAD51Y54pCMF, as 
well the number of molecules used to build each histogram are indicated in each panel. 
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Figure 3.9. Altered ssDNA binding of RAD51 Y54 and Y315 mutants 
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Figure 3.9. Altered ssDNA binding of RAD51 Y54 and Y315 mutants (A) FRET based assay 
to measure binding for RAD51 Y54 mutants to ssDNA. Under conditions inhibiting ATP 
hydrolysis (Ca2+) RAD51Y54D & RAD51Y54E mutants deviate from ideal RAD51 binding 
behavior. (B) This effect is significantly exaggerated under conditions permitting ATP hydrolysis 
(Mg2+) (C & D) Similar FRET based experiments were conducted for Y315 mutants which were 
observed to have similar ssDNA binding characteristics under both, prohibitive conditions for ATP 
hydrolysis (Ca2+) as well as permissive conditions (Mg2+). Data is represented as mean ± SEM 
with n = 3. (E) Rates of ssDNA dependent ATP hydrolysis of all RAD51 mutants measured using 
the coupled NADH assay. Data is represented as mean ± SEM with n = 3. 
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Figure 3.10. Single-Molecule TIRF ssDNA binding Assay (A) A Poly dT(60) ssDNA substrate is immobilized to a biotinylated 
quartz slide using the biotin-Neutravidin interaction (see methods). Evanescent wave produced by a prism-based total internal 
reflection (TIR) illumination and a 532nm laser is used to excite the Cy3 dye on the surface-tethered DNA substrate. In the absence 
of protein, the acceptor Cy5 dye on the partial duplex DNA is excited via FRET. Upon binding, RAD51 extends the ssDNA 
substrate leading to a decrease in energy transfer and reduction in Cy5 emission with a corresponding increase in Cy3 intensity. 
Both Cy3 and Cy5 emission can be tracked simultaneously using a dual view system. The change in Cy3 and Cy5 intensities on 
RAD51 binding to ssDNA substrate are tracked over time by recording movies over the course of the experiment.   
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Figure 3.11. Hidden Markov Analysis shows that RAD51 and RAD51Y54pCMF nucleate on ssDNA as dimers 
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Figure 3.11. Hidden Markov Analysis shows that RAD51 and RAD51Y54pCMF nucleate on 
ssDNA as dimers (A & B) Representative Cy3 (donor) and Cy5 (acceptor) trajectories from pre-
equilibrium experiments visualizing RAD51 (A) and RAD51Y54pCMF (B) nucleation onto ssDNA 
in real time. RAD51 protein was introduced into the reaction chamber at ~10 seconds into a 3 
minute recording. Trajectories that showed anti-correlated behavior were selected and corrected 
for background intensities as well as donor leakage followed by calculation of FRET trajectories. 
Regions containing transitions were trimmed and used for Hidden Markov analysis (ebFRET). The 
idealized trajectories are overlaid on the raw FRET trajectories showing the fit. . (C &D) 
Histograms showing distribution of observed FRET states from 281 and 179 molecules for RAD51 
(C) and RAD51Y54pCMF (D). Four distinct FRET states were observed with FRET values between 
0.5 and 0.1. Since the Cy3-Cy5 FRET pair is 21 nucleotides apart, this shows the RAD51 
molecules bound ssDNA in three steps indicating each step as a dimer.  
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Figure 3.12. Formation of the dynamic RAD51 nuclei vs directional nuclei formation by RAD51Y54pCMF. (A) Schematic 
explaining the 3D Transition Density Plots (TDP). Four distinct FRET states 1, 2, 3 and 4 correspond to respective states in the 
RAD51 nucleus formation on ssDNA with three steps between these states required to fully extend the ssDNA substrate. Transitions 
1→2→3→4 correspond to the filament formation, while filament disassembly is reflected in transitions in the reverse direction.  
(B) TDPs showing the transition densities corresponding to each state for the wild type RAD51 protein at increasing concentrations. 
The transitions were calculated from 85, 50 and 146 molecules for 250nM, 750nM and 2.5μM concentrations respectively. Brighter 
colors represent more frequent transitions. The frequency scale is shown on the right of the graphs.  (C) TDP plots showing 
transition densities for the RAD51Y54pCMF mutant. No transitions were observed at 250nM concentrations. Transitions were 
calculated from 63 and 116 molecules for 750nM and 2.5μM concentrations, respectively.  
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Figure 3.13. Effect of phosphomimetics on the RAD51 oligomerization Native-PAGE gel of all RAD51 mutants loaded at 
7.5μM concentration similar to that used in strand exchange assays. All RAD51 Y54 mutants except RAD51Y54F display increase 
in the electrophoretic mobility where the higher order oligomeric species are shifted to a lower molecular weight with more discrete 
bands.RAD51Y315D & RAD51Y315E mutants migrate higher compared to the Y54 mutants. A fraction of RAD51Y315pCMF formed 
higher molecular weight aggregates that were slow to enter the gel. 
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CONCLUSIONS & FUTURE DIRECTION 
In the work described in this dissertation, I have answered some fundamental questions regarding 
aspects of regulation of DNA repair by Homologous Recombination. My studies have focused 
mainly around the human RAD51 protein and its regulation in DNA repair. Using previously 
known structural information from the yeast Rad51 protein as well as information from a partial 
Human RAD51 crystal structure, I helped build and validate a homology model that explains the 
structural features of the complete RAD51 recombinase. Using this model, I was also able to 
describe new interactions between RAD51 protein and the BRCA2 tumor suppressor protein. 
These studies make significant contributions to the role of the BRCA2 mediator in RAD51 
mediated DNA repair.  
 Using information from the homology model, I decided to probe the mechanism of 
regulation of the RAD51 protein by the c-Abl/BCR-ABL kinase protein. Biochemical information 
on this topic is very sparse and conflicts with observation made in cellular studies. Using a novel 
method to incorporate and artificial amino acid pCMF that is a more relevant replacement for the 
a phosphotyrosine residue, I was able to reconcile results with cellular data and for the first time, 
provide a complete understanding of how c-Abl phosphorylation affects RAD51 mechanistically 
using high resolution single molecule methods and traditional biochemical and biophysical 
approaches.  
 The results of my studies and methods developed by me, will be used to further understand 
the regulation of the RAD51 protein as well as study other mediators and antirecombinases 
involved in homologous recombination which will generate insights into one of the most critical 
steps in DNA repair and to find an ‘Achilles Heel’ in RAD51 function and exploit it to develop 
novel anticancer therapies. 
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APPENDIX: IMPORTANT DNA SEQUENCES RELATED TO RAD51 STUDIES 
 
 
>Homo sapiens RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) (RAD51), 
transcript variant 1, CDS (SPIES LAB VERSION) 
ATGGCAATGCAGATGCAGCTTGAAGCAAATGCAGATACTTCAGTGGAAGAAGAAAGCTTTGGCCCACAACCCATTTC
ACGGTTAGAGCAGTGTGGCATAAATGCCAACGATGTGAAGAAATTGGAAGAAGCTGGATTCCATACTGTGGAGGCTG
TTGCCTATGCGCCAAAGAAGGAGCTAATAAATATTAAGGGAATTAGTGAAGCCAAAGCTGATAAAATTCTGGCTGAG
GCAGCTAAATTAGTTCCAATGGGTTTCACCACTGCAACTGAATTCCACCAAAGGCGGTCAGAGATCATACAGATTAC
TACTGGCTCCAAAGAGCTTGACAAACTACTTCAAGGTGGAATTGAGACTGGATCTATCACAGAAATGTTTGGAGAAT
TCCGAACTGGGAAGACCCAGATCTGTCATACGCTAGCTGTCACCTGCCAGCTTCCCATTGACCGGGGTGGAGGTGAA
GGAAAGGCCATGTACATTGACACTGAGGGTACCTTTAGGCCAGAACGGCTGCTGGCAGTGGCTGAGAGGTATGGTCT
CTCTGGCAGTGATGTCCTGGATAATGTAGCATATGCTCGAGCGTTCAACACAGACCACCAGACCCAGCTCCTTTATC
AAGCATCAGCCATGATGGTAGAATCTAGGTATGCACTGCTTATTGTAGACAGTGCCACCGCCCTTTACAGAACAGAC
TACTCGGGTCGAGGTGAGCTTTCAGCCAGGCAGATGCACTTGGCCAGGTTTCTGCGGATGCTTCTGCGACTCGCTGA
TGAGTTTGGTGTAGCAGTGGTAATCACTAATCAGGTGGTAGCTCAAGTGGATGGAGCAGCGATGTTTGCTGCTGATC
CCAAAAAACCTATTGGAGGAAATATCATCGCCCATGCATCAACAACCAGATTGTATCTGAGGAAAGGAAGAGGGGAA
ACCAGAATCTGCAAAATCTACGACTCTCCCTGTCTTCCTGAAGCTGAAGCTATGTTCGCCATTAATGCAGATGGAGT
GGGAGATGCCAAAGACTGA 
 
>gi|49168602|emb|CAG38796.1| RAD51 [Homo sapiens] 
MAMQMQLEANADTSVEEESFGPQPISRLEQCGINANDVKKLEEAGFHTVEAVAYAPKKELINIKGISEAKADKILAE
AAKLVPMGFTTATEFHQRRSEIIQITTGSKELDKLLQGGIETGSITEMFGEFRTGKTQICHTLAVTCQLPIDRGGGE
GKAMYIDTEGTFRPERLLAVAERYGLSGSDVLDNVAYARAFNTDHQTQLLYQASAMMVESRYALLIVDSATALYRTD
YSGRGELSARQMHLARFLRMLLRLADEFGVAVVITNQVVAQVDGAAMFAADPKKPIGGNIIAHASTTRLYLRKGRGE
TRICKIYDSPCLPEAEAMFAINADGVGDAKD* 
 
 
 
GEFRTGK – Walker A Domain 
RYALLIVDSATALYR – Walker B Domain 
TDYSGRG – DNA Binding Loop 1 
VDGAAMFAADPK – DNA Binding Loop 2 
PKKP – PXXP Consensus Sequence for c-Abl SH3 Binding 
YDSP – (p)YXXP Consensus Sequence for c-Abl SH2 Binding 
PCLP – PXXP Consensus Sequence for c-Abl SH3 Binding 
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>RAD51 (OPT) Sequence Codon Optimzed for E. coli expression  
ATGGCAATGCAGATGCAGCTGGAAGCGAACGCAGATACCTCAGTGGAAGAAGAAAGTTTTGGTCCGCAACCGATTAG
CCGCCTGGAACAGTGCGGTATCAACGCAAATGATGTGAAAAAGCTGGAAGAAGCTGGCTTTCATACCGTTGAAGCAG
TCGCTTATGCGCCGAAAAAGGAACTGATCAACATCAAGGGTATCAGCGAAGCCAAAGCAGACAAGATCCTGGCCGAA
GCGGCCAAACTGGTTCCGATGGGCTTTACCACGGCAACCGAATTTCATCAGCGTCGCAGCGAAATTATCCAAATTAC
CACGGGTTCTAAAGAACTGGATAAGCTGCTGCAGGGCGGTATTGAAACCGGCTCTATCACGGAAATGTTTGGTGAAT
TTCGCACCGGCAAAACGCAGATTTGCCACACCCTGGCGGTGACGTGTCAACTGCCGATCGATCGTGGCGGTGGCGAG
GGTAAAGCCATGTACATTGACACCGAAGGCACGTTTCGTCCGGAACGCCTGCTGGCTGTTGCGGAACGCTATGGTCT
GAGCGGCTCTGATGTGCTGGACAACGTTGCCTACGCACGTGCTTTCAATACCGATCATCAGACGCAACTGCTGTATC
AGGCGAGTGCCATGATGGTCGAATCCCGCTACGCGCTGCTGATTGTGGATAGCGCAACCGCTCTGTATCGTACGGAC
TACTCAGGTCGCGGCGAACTGTCGGCACGTCAAATGCACCTGGCTCGTTTTCTGCGCATGCTGCTGCGTCTGGCGGA
CGAATTTGGTGTTGCCGTGGTTATCACCAACCAGGTCGTGGCGCAAGTCGATGGCGCAGCTATGTTCGCGGCCGACC
CGAAAAAGCCGATTGGTGGCAATATTATCGCGCACGCCAGTACCACGCGCCTGTATCTGCGTAAAGGTCGCGGCGAA
ACCCGTATTTGCAAAATCTATGATTCCCCGTGTCTGCCGGAAGCCGAAGCCATGTTTGCCATCAATGCCGACGGTGT
TGGTGACGCTAAGGATTAA 
 
 
NcoI-RAD51o FP – AATAGCCCATGGCAATGCAGATGCAGCTGG 
NotI-RAD51o RP – GCTATTGCGGCCGCTTAATCCTTAGCGTCACCAACACCGTC 
NcoI-RAD51o FPN - TAAATAGCCCATGGCAATGCAGATGCAGCTGG 
NotI-RAD51o RPN – ATGCTATTGCGGCCGCTTAATCCTTAGCGTCACCAACACCGTC 
RAD51o F1 - TCGCACCGGCAAAACGCAG 
RAD51o R1 – TCAGAGCCGCTCAGACCATAGC 
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>pCOLADuet-1/GroE/RAD51_OPT (pCH1-RAD51Opt) 
ggggaattgtgagcggataacaattcccctgtagaaataattttgtttaactttaataaggagatataCCATGGCAA
TGCAGATGCAGCTGGAAGCGAACGCAGATACCTCAGTGGAAGAAGAAAGTTTTGGTCCGCAACCGATTAGCCGCCTG
GAACAGTGCGGTATCAACGCAAATGATGTGAAAAAGCTGGAAGAAGCTGGCTTTCATACCGTTGAAGCAGTCGCTTA
TGCGCCGAAAAAGGAACTGATCAACATCAAGGGTATCAGCGAAGCCAAAGCAGACAAGATCCTGGCCGAAGCGGCCA
AACTGGTTCCGATGGGCTTTACCACGGCAACCGAATTTCATCAGCGTCGCAGCGAAATTATCCAAATTACCACGGGT
TCTAAAGAACTGGATAAGCTGCTGCAGGGCGGTATTGAAACCGGCTCTATCACGGAAATGTTTGGTGAATTTCGCAC
CGGCAAAACGCAGATTTGCCACACCCTGGCGGTGACGTGTCAACTGCCGATCGATCGTGGCGGTGGCGAGGGTAAAG
CCATGTACATTGACACCGAAGGCACGTTTCGTCCGGAACGCCTGCTGGCTGTTGCGGAACGCTATGGTCTGAGCGGC
TCTGATGTGCTGGACAACGTTGCCTACGCACGTGCTTTCAATACCGATCATCAGACGCAACTGCTGTATCAGGCGAG
TGCCATGATGGTCGAATCCCGCTACGCGCTGCTGATTGTGGATAGCGCAACCGCTCTGTATCGTACGGACTACTCAG
GTCGCGGCGAACTGTCGGCACGTCAAATGCACCTGGCTCGTTTTCTGCGCATGCTGCTGCGTCTGGCGGACGAATTT
GGTGTTGCCGTGGTTATCACCAACCAGGTCGTGGCGCAAGTCGATGGCGCAGCTATGTTCGCGGCCGACCCGAAAAA
GCCGATTGGTGGCAATATTATCGCGCACGCCAGTACCACGCGCCTGTATCTGCGTAAAGGTCGCGGCGAAACCCGTA
TTTGCAAAATCTATGATTCCCCGTGTCTGCCGGAAGCCGAAGCCATGTTTGCCATCAATGCCGACGGTGTTGGTGAC
GCTAAGGATTAAGCGGCCGCataatgcttaagtcgaacagaaagtaatcgtattgtacacggccgcataatcgaaat
taatacgactcactataggggaattgtgagcggataacaattccccatcttagtatattagttaagtataagaagga
gatataCATATGAATATTCGTCCATTGCATGATCGCGTGATCGTCAAGCGTAAAGAAGTTGAAACTAAATCTGCTGG
CGGCATCGTTCTGACCGGCTCTGCAGCGGCTAAATCCACCCGCGGCGAAGTGCTGGCTGTCGGCAATGGCCGTATCC
TTGAAAATGGCGAAGTGAAGCCGCTGGATGTGAAAGTTGGCGACATCGTTATTTTCAACGATGGCTACGGTGTGAAA
TCTGAGAAGATCGACAATGAAGAAGTGTTGATCATGTCCGAAAGCGACATTCTGGCAATTGTTGAAGCGTAATCCGC
GCACGACACTGAACATACGAATTTAAGGAATAAAGATAATGGCAGCTAAAGACGTAAAATTCGGTAACGACGCTCGT
GTGAAAATGCTGCGCGGCGTAAACGTACTGGCAGATGCAGTGAAAGTTACCCTCGGTCCAAAAGGCCGTAACGTAGT
TCTGGATAAATCTTTCGGTGCACCGACCATCACCAAAGATGGTGTTTCCGTTGCTCGTGAAATCGAACTGGAAGACA
AGTTCGAAAATATGGGTGCGCAGATGGTGAAAGAAGTTGCCTCTAAAGCAAACGACGCTGCAGGCGACGGTACCACC
ACTGCAACCGTACTGGCTCAGGCTATCATCACTGAAGGTCTGAAAGCTGTTGCTGCGGGCATGAACCCGATGGACCT
GAAACGTGGTATCGACAAAGCGGTTACCGTTGCAGTTGAAGAACTGAAAGCGCTGTCCGTACCATGCTCTGACTCTA
AAGCGATTGCTCAGGTTGGTACCATCTCCGCTAACTCCGACGAAACCGTAGGTAAACTGATCGCTGAAGCGATGGAC
AAAGTCGGTAAAGAAGGCGTTATCACCGTTGAAGACGGTACCGGTCTGCAGGACGAACTGGACGTGGTTGAAGGTAT
GCAGTTCGACCGTGGCTACCTGTCTCCTTACTTCATCAACAAGCCGGAAACTGGCGCAGTAGAACTGGAAAGCCCGT
TCATCCTGCTGGCTGACAAGAAAATCTCCAACATCCGCGAAATGCTGCCGGTTCTGGAAGCTGTTGCCAAAGCAGGC
AAACCGCTGCTGATCATCGCTGAAGATGTAGAAGGCGAAGCGCTGGCAACTCTGGTTGTTAACACCATGCGTGGCAT
CGTGAAAGTCGCTGCGGTTAAAGCACCGGGCTTCGGCGATCGTCGTAAAGCTATGCTGCAGGATATCGCAACCCTGA
CTGGCGGTACCGTGATCTCTGAAGAGATCGGTATGGAGCTGGAAAAAGCAACCCTGGAAGACCTGGGTCAGGCTAAA
CGTGTTGTGATCAACAAAGACACCACCACTATCATCGATGGCGTGGGTGAAGAAGCTGCAATCCAGGGCCGTGTTGC
TCAGATCCGTCAGCAGATTGAAGAAGCAACTTCTGACTACGACCGTGAAAAACTGCAGGAACGCGTAGCGAAACTGG
CAGGCGGCGTTGCAGTTATCAAAGTGGGTGCTGCTACCGAAGTTGAAATGAAAGAGAAAAAAGCACGCGTTGAAGAT
GCCCTGCACGCGACCCGTGCTGCGGTAGAAGAAGGCGTGGTTGCTGGTGGTGGTGTTGCGCTGATCCGCGTAGCGTC
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TAAACTGGCTGACCTGCGTGGTCAGAACGAAGACCAGAACGTGGGTATCAAAGTTGCACTGCGTGCAATGGAAGCTC
CGCTGCGTCAGATCGTATTGAACTGCGGCGAAGAACCGTCTGTTGTTGCTAACACCGTTAAAGGCGGCGACGGCAAC
TACGGTTACAACGCAGCAACCGAAGAATACGGCAACATGATCGACATGGGTATCCTGGATCCAACCAAAGTAACTCG
TTCTGCTCTGCAGTACGCAGCTTCTGTGGCTGGCCTGATGATCACCACCGAATGCATGGTTACCGACCTGCCGAAAA
ACGATGCAGCTGACTTAGGCGCTGCTGGCGGTATGGGCGGCATGGGTGGCATGGGCGGCATGATGTAAAGATCTcaa
ttggatatcggccggccacgcgatcgctgacgtcggtaccctcgagtctggtaaagaaaccgctgctgcgaaatttg
aacgccagcacatggactcgtctactagcgcagcttaattaacctaggctgctgccaccgctgagcaataactagca
taaccccttggggcctctaaacgggtcttgaggggttttttgctgaaacctcaggcatttgagaagcacacggtcac
actgcttccggtagtcaataaaccggtaaaccagcaatagacataagcggctatttaacgaccctgccctgaaccga
cgacaagctgacgaccgggtctccgcaagtggcacttttcggggaaatgtgcgcggaacccctatttgtttattttt
ctaaatacattcaaatatgtatccgctcatgaattaattcttagaaaaactcatcgagcatcaaatgaaactgcaat
ttattcatatcaggattatcaataccatatttttgaaaaagccgtttctgtaatgaaggagaaaactcaccgaggca
gttccataggatggcaagatcctggtatcggtctgcgattccgactcgtccaacatcaatacaacctattaaGCCGC
tttcccctcgtcaaaaataaggttatcaagtgagaaatcaccatgagtgacgactgaatccggtgagaatggcaaaa
gtttatgcatttctttccagacttgttcaacaggccagccattacgctcgtcatcaaaatcactcgcatcaaccaaa
ccgttattcattcgtgattgcgcctgagcgagacgaaatacgcggtcgctgttaaaaggacaattacaaacaggaat
cgaatgcaaccggcgcaggaacactgccagcgcatcaacaatattttcacctgaatcaggatattcttctaatacct
ggaatgctgttttcccggggatcgcagtggtgagtaaccatgcatcatcaggagtacggataaaatgcttgatggtc
ggaagaggcataaattccgtcagccagtttagtctgaccatctcatctgtaacatcattggcaacgctacctttgcc
atgtttcagaaacaactctggcgcatcgggcttcccatacaatcgatagattgtcgcacctgattgcccgacattat
cgcgagcccatttatacccatataaatcagcatccatgttggaatttaatcgcggcctagagcaagacgtttcccgt
tgaatatggctcatactcttcctttttcaatattattgaagcatttatcagggttattgtctcatgagcggatacat
atttgaatgtatttagaaaaataaacaaataggcatgctagcgcagaaacgtcctagaagatgccaggaggatactt
agcagagagacaataaggccggagcgaagccgtttttccataggctccgcccccctgacgaacatcacgaaatctga
cgctcaaatcagtggtggcgaaacccgacaggactataaagataccaggcgtttccccctgatggctccctcttgcg
ctctcctgttcccgtcctgcggcgtccgtgttgtggtggaggctttacccaaatcaccacgtcccgttccgtgtaga
cagttcgctccaagctgggctgtgtgcaagaaccccccgttcagcccgactgctgcgccttatccggtaactatcat
cttgagtccaacccggaaagacacgacaaaacgccactggcagcagccattggtaactgagaattagtggatttaga
tatcgagagtcttgaagtggtggcctaacagaggctacactgaaaggacagtatttggtatctgcgctccactaaag
ccagttaccaggttaagcagttccccaactgacttaaccttcgatcaaaccgcctccccaggcggttttttcgttta
cagagcaggagattacgacgatcgtaaaaggatctcaagaagatcctttacggattcccgacaccatcactctagat
ttcagtgcaatttatctcttcaaatgtagcacctgaagtcagccccatacgatataagttgtaattctcatgttagt
catgccccgcgcccaccggaaggagctgactgggttgaaggctctcaagggcatcggtcgagatcccggtgcctaat
gagtgagctaacttacattaattgcgttgcgctcactgcccgctttccagtcgggaaacctgtcgtgccagctgcat
taatgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgccagggtggtttttcttttcaccagtgaga
cgggcaacagctgattgcccttcaccgcctggccctgagagagttgcagcaagcggtccacgctggtttgccccagc
aggcgaaaatcctgtttgatggtggttaacggcgggatataacatgagctgtcttcggtatcgtcgtatcccactac
cgagatgtccgcaccaacgcgcagcccggactcggtaatggcgcgcattgcgcccagcgccatctgatcgttggcaa
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ccagcatcgcagtgggaacgatgccctcattcagcatttgcatggtttgttgaaaaccggacatggcactccagtcg
ccttcccgttccgctatcggctgaatttgattgcgagtgagatatttatgccagccagccagacgcagacgcgccga
gacagaacttaatgggcccgctaacagcgcgatttgctggtgacccaatgcgaccagatgctccacgcccagtcgcg
taccgtcttcatgggagaaaataatactgttgatgggtgtctggtcagagacatcaagaaataacgccggaacatta
gtgcaggcagcttccacagcaatggcatcctggtcatccagcggatagttaatgatcagcccactgacgcgttgcgc
gagaagattgtgcaccgccgctttacaggcttcgacgccgcttcgttctaccatcgacaccaccacgctggcaccca
gttgatcggcgcgagatttaatcgccgcgacaatttgcgacggcgcgtgcagggccagactggaggtggcaacgcca
atcagcaacgactgtttgcccgccagttgttgtgccacgcggttgggaatgtaattcagctccgccatcgccgcttc
cactttttcccgcgttttcgcagaaacgtggctggcctggttcaccacgcgggaaacggtctgataagagacaccgg
catactctgcgacatcgtataacgttactggtttcacattcaccaccctgaattgactctcttccgggcgctatcat
gccataccgcgaaaggttttgcgccattcgatggtgtccgggatctcgacgctctcccttatgcgactcctgcatta
ggaaattaatacgactcactata 
 
 
>MCS1-RAD51 OPT 
aatagcCCATGGCAATGCAGATGCAGCTGGAAGCGAACGCAGATACCTCAGTGGAAGAAGAAAGTTTTGGTCCGCAA
CCGATTAGCCGCCTGGAACAGTGCGGTATCAACGCAAATGATGTGAAAAAGCTGGAAGAAGCTGGCTTTCATACCGT
TGAAGCAGTCGCTTATGCGCCGAAAAAGGAACTGATCAACATCAAGGGTATCAGCGAAGCCAAAGCAGACAAGATCC
TGGCCGAAGCGGCCAAACTGGTTCCGATGGGCTTTACCACGGCAACCGAATTTCATCAGCGTCGCAGCGAAATTATC
CAAATTACCACGGGTTCTAAAGAACTGGATAAGCTGCTGCAGGGCGGTATTGAAACCGGCTCTATCACGGAAATGTT
TGGTGAATTTCGCACCGGCAAAACGCAGATTTGCCACACCCTGGCGGTGACGTGTCAACTGCCGATCGATCGTGGCG
GTGGCGAGGGTAAAGCCATGTACATTGACACCGAAGGCACGTTTCGTCCGGAACGCCTGCTGGCTGTTGCGGAACGC
TATGGTCTGAGCGGCTCTGATGTGCTGGACAACGTTGCCTACGCACGTGCTTTCAATACCGATCATCAGACGCAACT
GCTGTATCAGGCGAGTGCCATGATGGTCGAATCCCGCTACGCGCTGCTGATTGTGGATAGCGCAACCGCTCTGTATC
GTACGGACTACTCAGGTCGCGGCGAACTGTCGGCACGTCAAATGCACCTGGCTCGTTTTCTGCGCATGCTGCTGCGT
CTGGCGGACGAATTTGGTGTTGCCGTGGTTATCACCAACCAGGTCGTGGCGCAAGTCGATGGCGCAGCTATGTTCGC
GGCCGACCCGAAAAAGCCGATTGGTGGCAATATTATCGCGCACGCCAGTACCACGCGCCTGTATCTGCGTAAAGGTC
GCGGCGAAACCCGTATTTGCAAAATCTATGATTCCCCGTGTCTGCCGGAAGCCGAAGCCATGTTTGCCATCAATGCC
GACGGTGTTGGTGACGCTAAGGATTAAGCGGCCGCaatagcat 
 
Cloning and sequencing primers 
NcoI-RAD51o FP – AATAGCCCATGGCAATGCAGATGCAGCTGG 
NotI-RAD51o RP – GCTATTGCGGCCGCTTAATCCTTAGCGTCACCAACACCGTC 
NcoI-RAD51o FPN - TAAATAGCCCATGGCAATGCAGATGCAGCTGG 
NotI-RAD51o RPN – ATGCTATTGCGGCCGCTTAATCCTTAGCGTCACCAACACCGTC 
RAD51o F1 - TCGCACCGGCAAAACGCAG 
RAD51o R1 – TCAGAGCCGCTCAGACCATAGC 
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>MCS2-GroE Operon 
aatagcCATATGAATATTCGTCCATTGCATGATCGCGTGATCGTCAAGCGTAAAGAAGTTGAAACTAAATCTGCTGG
CGGCATCGTTCTGACCGGCTCTGCAGCGGCTAAATCCACCCGCGGCGAAGTGCTGGCTGTCGGCAATGGCCGTATCC
TTGAAAATGGCGAAGTGAAGCCGCTGGATGTGAAAGTTGGCGACATCGTTATTTTCAACGATGGCTACGGTGTGAAA
TCTGAGAAGATCGACAATGAAGAAGTGTTGATCATGTCCGAAAGCGACATTCTGGCAATTGTTGAAGCGTAATCCGC
GCACGACACTGAACATACGAATTTAAGGAATAAAGATAATGGCAGCTAAAGACGTAAAATTCGGTAACGACGCTCGT
GTGAAAATGCTGCGCGGCGTAAACGTACTGGCAGATGCAGTGAAAGTTACCCTCGGTCCAAAAGGCCGTAACGTAGT
TCTGGATAAATCTTTCGGTGCACCGACCATCACCAAAGATGGTGTTTCCGTTGCTCGTGAAATCGAACTGGAAGACA
AGTTCGAAAATATGGGTGCGCAGATGGTGAAAGAAGTTGCCTCTAAAGCAAACGACGCTGCAGGCGACGGTACCACC
ACTGCAACCGTACTGGCTCAGGCTATCATCACTGAAGGTCTGAAAGCTGTTGCTGCGGGCATGAACCCGATGGACCT
GAAACGTGGTATCGACAAAGCGGTTACCGTTGCAGTTGAAGAACTGAAAGCGCTGTCCGTACCATGCTCTGACTCTA
AAGCGATTGCTCAGGTTGGTACCATCTCCGCTAACTCCGACGAAACCGTAGGTAAACTGATCGCTGAAGCGATGGAC
AAAGTCGGTAAAGAAGGCGTTATCACCGTTGAAGACGGTACCGGTCTGCAGGACGAACTGGACGTGGTTGAAGGTAT
GCAGTTCGACCGTGGCTACCTGTCTCCTTACTTCATCAACAAGCCGGAAACTGGCGCAGTAGAACTGGAAAGCCCGT
TCATCCTGCTGGCTGACAAGAAAATCTCCAACATCCGCGAAATGCTGCCGGTTCTGGAAGCTGTTGCCAAAGCAGGC
AAACCGCTGCTGATCATCGCTGAAGATGTAGAAGGCGAAGCGCTGGCAACTCTGGTTGTTAACACCATGCGTGGCAT
CGTGAAAGTCGCTGCGGTTAAAGCACCGGGCTTCGGCGATCGTCGTAAAGCTATGCTGCAGGATATCGCAACCCTGA
CTGGCGGTACCGTGATCTCTGAAGAGATCGGTATGGAGCTGGAAAAAGCAACCCTGGAAGACCTGGGTCAGGCTAAA
CGTGTTGTGATCAACAAAGACACCACCACTATCATCGATGGCGTGGGTGAAGAAGCTGCAATCCAGGGCCGTGTTGC
TCAGATCCGTCAGCAGATTGAAGAAGCAACTTCTGACTACGACCGTGAAAAACTGCAGGAACGCGTAGCGAAACTGG
CAGGCGGCGTTGCAGTTATCAAAGTGGGTGCTGCTACCGAAGTTGAAATGAAAGAGAAAAAAGCACGCGTTGAAGAT
GCCCTGCACGCGACCCGTGCTGCGGTAGAAGAAGGCGTGGTTGCTGGTGGTGGTGTTGCGCTGATCCGCGTAGCGTC
TAAACTGGCTGACCTGCGTGGTCAGAACGAAGACCAGAACGTGGGTATCAAAGTTGCACTGCGTGCAATGGAAGCTC
CGCTGCGTCAGATCGTATTGAACTGCGGCGAAGAACCGTCTGTTGTTGCTAACACCGTTAAAGGCGGCGACGGCAAC
TACGGTTACAACGCAGCAACCGAAGAATACGGCAACATGATCGACATGGGTATCCTGGATCCAACCAAAGTAACTCG
TTCTGCTCTGCAGTACGCAGCTTCTGTGGCTGGCCTGATGATCACCACCGAATGCATGGTTACCGACCTGCCGAAAA
ACGATGCAGCTGACTTAGGCGCTGCTGGCGGTATGGGCGGCATGGGTGGCATGGGCGGCATGATGTAAAGATCTaat
agc 
 
Cloning and Sequencing Primers 
NdeI-GroE FP – AATAGCCATATGAATATTCGTCCATTGCATGATCG 
BglII-GroE RP – GCTATTAGATCTTTACATCATGCCGCCCATGCCAC 
GROE RP1 - ACGCGGATCAGCGCAACACCAC 
GROE RP2 – TCCGGCTTGTTGATGAAGTAAGGAG 
GROE RP3 – ACTGCATCTGCCAGTACGTTTACG 
COLAORF2 FP – CGTATTGTACACGGCCGCATAATCG 
COLAORF2 RP - CGATTATGCGGCCGTGTACAATACG 
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Vector Map of the pCH1-RAD51Opt Plasmid 
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Vector Map of the pSUPT-uaaRS Plasmid 
 
  
